                                                                                                                                   II




                                  113TH CONGRESS
                                     1ST SESSION                            S. 242
                                  To reauthorize certain programs under the Public Health Service Act and
                                      the Federal Food, Drug, and Cosmetic Act with respect to public health
                                      security and all-hazards preparedness and response, and for other pur-
                                      poses.




                                              IN THE SENATE OF THE UNITED STATES
                                                                FEBRUARY 7, 2013
                                  Mr. BURR (for himself, Mr. HARKIN, Mr. ENZI, Mr. CASEY, Mr. ALEXANDER,
                                      Ms. MIKULSKI, Mr. ISAKSON, Mr. ROBERTS, and Mr. CHAMBLISS) intro-
                                      duced the following bill; which was read twice and referred to the Com-
                                      mittee on Health, Education, Labor, and Pensions




                                                                            A BILL
                                  To reauthorize certain programs under the Public Health
                                     Service Act and the Federal Food, Drug, and Cosmetic
                                     Act with respect to public health security and all-hazards
                                     preparedness and response, and for other purposes.
                                    1              Be it enacted by the Senate and House of Representa-
                                    2 tives of the United States of America in Congress assembled,
                                    3     SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

                                    4              (a) SHORT TITLE.—This Act may be cited as the
                                    5 ‘‘Pandemic and All-Hazards Preparedness Reauthoriza-




                                    6 tion Act of 2013’’.
                                                                                             2
                                    1              (b) TABLE            OF    CONTENTS.—The table of contents of
                                    2 this Act is as follows:
                                          Sec. 1. Short title; table of contents.

                                                TITLE I—STRENGTHENING NATIONAL PREPAREDNESS AND
                                                     RESPONSE FOR PUBLIC HEALTH EMERGENCIES

                                          Sec.   101.      National Health Security Strategy.
                                          Sec.   102.      Assistant Secretary for Preparedness and Response.
                                          Sec.   103.      National Advisory Committee on Children and Disasters.
                                          Sec.   104.      Modernization of the National Disaster Medical System.
                                          Sec.   105.      Continuing the role of the Department of Veterans Affairs.

                                                  TITLE II—OPTIMIZING STATE AND LOCAL ALL-HAZARDS
                                                            PREPAREDNESS AND RESPONSE

                                          Sec. 201. Temporary reassignment of State and local personnel during a public
                                                          health emergency.
                                          Sec. 202. Improving State and local public health security.
                                          Sec. 203. Hospital preparedness and medical surge capacity.
                                          Sec. 204. Enhancing situational awareness and biosurveillance.
                                          Sec. 205. Eliminating duplicative Project Bioshield reports.

                                              TITLE III—ENHANCING MEDICAL COUNTERMEASURE REVIEW

                                          Sec.   301.      Special protocol assessment.
                                          Sec.   302.      Authorization for medical products for use in emergencies.
                                          Sec.   303.      Definitions.
                                          Sec.   304.      Enhancing medical countermeasure activities.
                                          Sec.   305.      Regulatory management plans.
                                          Sec.   306.      Report.
                                          Sec.   307.      Pediatric medical countermeasures.

                                                  TITLE IV—ACCELERATING MEDICAL COUNTERMEASURE
                                                       ADVANCED RESEARCH AND DEVELOPMENT

                                          Sec.   401.      BioShield.
                                          Sec.   402.      Biomedical Advanced Research and Development Authority.
                                          Sec.   403.      Strategic National Stockpile.
                                          Sec.   404.      National Biodefense Science Board.





                                              •S 242 IS

                                    1     TITLE I—STRENGTHENING NA-                        3
                                    2        TIONAL PREPAREDNESS AND
                                    3        RESPONSE   FOR   PUBLIC
                                    4        HEALTH EMERGENCIES
                                    5     SEC. 101. NATIONAL HEALTH SECURITY STRATEGY.

                                    6              (a) IN GENERAL.—Section 2802 of the Public Health
                                    7 Service Act (42 U.S.C. 300hh–1) is amended—
                                    8                        (1) in subsection (a)(1), by striking ‘‘2009’’ and
                                    9              inserting ‘‘2014’’; and
                                  10                         (2) in subsection (b)—
                                  11                                  (A) in paragraph (1)(A), by inserting ‘‘,
                                  12                         including drills and exercises to ensure medical
                                  13                         surge capacity for events without notice’’ after
                                  14                         ‘‘exercises’’; and
                                  15                                  (B) in paragraph (3)—
                                  16                                         (i) in the matter preceding subpara-
                                  17                                  graph (A)—
                                  18                                                   (I) by striking ‘‘facilities), and
                                  19                                         trauma care’’ and inserting ‘‘and am-
                                  20                                         bulatory care facilities and which may
                                  21                                         include dental health facilities), and
                                  22                                         trauma care, critical care,’’; and
                                  23                                                   (II) by inserting ‘‘(including re-
                                  24                                         lated availability, accessibility, and co-





                                              •S 242 IS

                                                                                             4
                                    1                                        ordination)’’                after         ‘‘public   health
                                    2                                        emergencies’’;
                                    3                                        (ii) in subparagraph (A), by inserting
                                    4                                 ‘‘and trauma’’ after ‘‘medical’’;
                                    5                                        (iii) in subparagraph (B), by striking
                                    6                                 ‘‘Medical evacuation and fatality manage-
                                    7                                 ment’’ and inserting ‘‘Fatality manage-
                                    8                                 ment’’;
                                    9                                        (iv) by redesignating subparagraphs
                                  10                                  (C), (D), and (E) as subparagraphs (D),
                                  11                                  (E), and (F), respectively;
                                  12                                         (v) by inserting after subparagraph
                                  13                                  (B), the following the new subparagraph:
                                  14                                  ‘‘(C) Coordinated medical triage and evac-
                                  15                         uation to appropriate medical institutions based
                                  16                         on patient medical need, taking into account re-
                                  17                         gionalized systems of care.’’;
                                  18                                         (vi) in subparagraph (E), as redesig-
                                  19                                  nated by clause (iv), by inserting ‘‘(which
                                  20                                  may include such dental health assets)’’
                                  21                                  after ‘‘medical assets’’; and
                                  22                                         (vii) by adding at the end the fol-
                                  23                                  lowing:
                                  24                                  ‘‘(G) Optimizing a coordinated and flexible




                                  25                         approach to the medical surge capacity of hos-
                                              •S 242 IS

                                                                                             5
                                    1                        pitals, other health care facilities, critical care,
                                    2                        trauma care (which may include trauma cen-
                                    3                        ters), and emergency medical systems.’’;
                                    4                                 (C) in paragraph (4)—
                                    5                                        (i) in subparagraph (A), by inserting
                                    6                                 ‘‘, including the unique needs and consider-
                                    7                                 ations of individuals with disabilities,’’
                                    8                                 after ‘‘medical needs of at-risk individ-
                                    9                                 uals’’; and
                                  10                                         (ii) in subparagraph (B), by inserting
                                  11                                  ‘‘the’’ before ‘‘purpose of this section’’; and
                                  12                                  (D) by adding at the end the following:
                                  13                         ‘‘(7) COUNTERMEASURES.—
                                  14                                  ‘‘(A) Promoting strategic initiatives to ad-
                                  15                         vance countermeasures to diagnose, mitigate,
                                  16                         prevent, or treat harm from any biological
                                  17                         agent or toxin, chemical, radiological, or nuclear
                                  18                         agent or agents, whether naturally occurring,
                                  19                         unintentional, or deliberate.
                                  20                                  ‘‘(B) For purposes of this paragraph, the
                                  21                         term ‘countermeasures’ has the same meaning
                                  22                         as the terms ‘qualified countermeasures’ under
                                  23                         section 319F–1, ‘qualified pandemic and epi-
                                  24                         demic products’ under section 319F–3, and ‘se-




                                  25                         curity countermeasures’ under section 319F–2.
                                              •S 242 IS

                                    1                        ‘‘(8) MEDICAL               6   AND PUBLIC HEALTH COMMU-
                                    2              NITY         RESILIENCY.—Strengthening                                   the ability of
                                    3              States, local communities, and tribal communities to
                                    4              prepare for, respond to, and be resilient in the event
                                    5              of public health emergencies, whether naturally oc-
                                    6              curring, unintentional, or deliberate by—
                                    7                                 ‘‘(A) optimizing alignment and integration
                                    8                        of medical and public health preparedness and
                                    9                        response planning and capabilities with and into
                                  10                         routine daily activities; and
                                  11                                  ‘‘(B) promoting familiarity with local med-
                                  12                         ical and public health systems.’’.
                                  13               (b) AT-RISK INDIVIDUALS.—Section 2814 of the
                                  14 Public Health Service Act (42 U.S.C. 300hh–16) is
                                  15 amended—
                                  16                         (1) by striking paragraphs (5), (7), and (8);
                                  17                         (2)         in         paragraph                 (4),           by    striking
                                  18               ‘‘2811(b)(3)(B)’’ and inserting ‘‘2802(b)(4)(B)’’;
                                  19                         (3) by redesignating paragraphs (1) through
                                  20               (4) as paragraphs (2) through (5), respectively;
                                  21                         (4) by inserting before paragraph (2) (as so re-
                                  22               designated), the following:
                                  23                         ‘‘(1) monitor emerging issues and concerns as
                                  24               they relate to medical and public health prepared-




                                  25               ness and response for at-risk individuals in the event
                                              •S 242 IS

                                                                                             7
                                    1              of a public health emergency declared by the Sec-
                                    2              retary under section 319;’’;
                                    3                        (5) by amending paragraph (2) (as so redesig-
                                    4              nated) to read as follows:
                                    5                        ‘‘(2) oversee the implementation of the pre-
                                    6              paredness goals described in section 2802(b) with re-
                                    7              spect to the public health and medical needs of at-
                                    8              risk individuals in the event of a public health emer-
                                    9              gency, as described in section 2802(b)(4);’’; and
                                  10                         (6) by inserting after paragraph (6), the fol-
                                  11               lowing:
                                  12                         ‘‘(7) disseminate and, as appropriate, update
                                  13               novel and best practices of outreach to and care of
                                  14               at-risk individuals before, during, and following pub-
                                  15               lic health emergencies in as timely a manner as is
                                  16               practicable, including from the time a public health
                                  17               threat is identified; and
                                  18                         ‘‘(8) ensure that public health and medical in-
                                  19               formation distributed by the Department of Health
                                  20               and Human Services during a public health emer-
                                  21               gency is delivered in a manner that takes into ac-
                                  22               count the range of communication needs of the in-
                                  23               tended recipients, including at-risk individuals.’’.





                                              •S 242 IS

                                    1     SEC. 102. ASSISTANT SECRETARY FOR PREPAREDNESS AND 8
                                    2                             RESPONSE.

                                    3              (a) IN GENERAL.—Section 2811 of the Public Health
                                    4 Service Act (42 U.S.C. 300hh–10) is amended—
                                    5                        (1) in subsection (b)—
                                    6                                 (A) in paragraph (3), by inserting ‘‘, secu-
                                    7                        rity countermeasures (as defined in section
                                    8                        319F–2),’’ after ‘‘qualified countermeasures (as
                                    9                        defined in section 319F–1)’’;
                                  10                                  (B) in paragraph (4), by adding at the end
                                  11                         the following:
                                  12                                  ‘‘(D) POLICY               COORDINATION AND STRA-
                                  13                         TEGIC DIRECTION.—Provide                                integrated policy
                                  14                         coordination and strategic direction with re-
                                  15                         spect to all matters related to Federal public
                                  16                         health and medical preparedness and execution
                                  17                         and deployment of the Federal response for
                                  18                         public health emergencies and incidents covered
                                  19                         by the National Response Plan developed pur-
                                  20                         suant to section 504(6) of the Homeland Secu-
                                  21                         rity Act of 2002, or any successor plan, before,
                                  22                         during, and following public health emergencies.
                                  23                                  ‘‘(E) IDENTIFICATION                           OF        INEFFICIEN-
                                  24                         CIES.—Identify              and minimize gaps, duplication,




                                  25                         and other inefficiencies in medical and public
                                  26                         health preparedness and response activities and
                                              •S 242 IS

                                                                                             9
                                    1                        the actions necessary to overcome these obsta-
                                    2                        cles.
                                    3                                 ‘‘(F) COORDINATION                          OF        GRANTS    AND
                                    4                        AGREEMENTS.—Align                           and coordinate medical
                                    5                        and public health grants and cooperative agree-
                                    6                        ments as applicable to preparedness and re-
                                    7                        sponse activities authorized under this Act, to
                                    8                        the extent possible, including program require-
                                    9                        ments, timelines, and measurable goals, and in
                                  10                         consultation with the Secretary of Homeland
                                  11                         Security, to—
                                  12                                         ‘‘(i) optimize and streamline medical
                                  13                                  and public health preparedness and re-
                                  14                                  sponse capabilities and the ability of local
                                  15                                  communities to respond to public health
                                  16                                  emergencies; and
                                  17                                         ‘‘(ii) gather and disseminate best
                                  18                                  practices among grant and cooperative
                                  19                                  agreement recipients, as appropriate.
                                  20                                  ‘‘(G) DRILL                AND         OPERATIONAL             EXER-
                                  21                         CISES.—Carry               out drills and operational exer-
                                  22                         cises, in consultation with the Department of
                                  23                         Homeland Security, the Department of De-
                                  24                         fense, the Department of Veterans Affairs, and




                                  25                         other applicable Federal departments and agen-
                                              •S 242 IS

                                                                                         10
                                    1                        cies, as necessary and appropriate, to identify,
                                    2                        inform, and address gaps in and policies related
                                    3                        to all-hazards medical and public health pre-
                                    4                        paredness and response, including exercises
                                    5                        based on—
                                    6                                        ‘‘(i) identified threats for which coun-
                                    7                                 termeasures are available and for which no
                                    8                                 countermeasures are available; and
                                    9                                        ‘‘(ii) unknown threats for which no
                                  10                                  countermeasures are available.
                                  11                                  ‘‘(H) NATIONAL                 SECURITY PRIORITY.—On
                                  12                         a periodic basis consult with, as applicable and
                                  13                         appropriate, the Assistant to the President for
                                  14                         National Security Affairs, to provide an update
                                  15                         on, and discuss, medical and public health pre-
                                  16                         paredness and response activities pursuant to
                                  17                         this Act and the Federal Food, Drug, and Cos-
                                  18                         metic Act, including progress on the develop-
                                  19                         ment, approval, clearance, and licensure of
                                  20                         medical countermeasures.’’; and
                                  21                                  (C) by adding at the end the following:
                                  22                         ‘‘(7) COUNTERMEASURES                            BUDGET PLAN.—De-
                                  23               velop, and update on an annual basis, a coordinated
                                  24               5-year budget plan based on the medical counter-





                                              •S 242 IS

                                                                                         11
                                    1              measure priorities described in subsection (d). Each
                                    2              such plan shall—
                                    3                                 ‘‘(A) include consideration of the entire
                                    4                        medical countermeasures enterprise, includ-
                                    5                        ing—
                                    6                                        ‘‘(i) basic research and advanced re-
                                    7                                 search and development;
                                    8                                        ‘‘(ii) approval, clearance, licensure,
                                    9                                 and authorized uses of products; and
                                  10                                         ‘‘(iii) procurement, stockpiling, main-
                                  11                                  tenance, and replenishment of all products
                                  12                                  in the Strategic National Stockpile;
                                  13                                  ‘‘(B) inform prioritization of resources and
                                  14                         include measurable outputs and outcomes to
                                  15                         allow for the tracking of the progress made to-
                                  16                         ward identified priorities;
                                  17                                  ‘‘(C) identify medical countermeasure life-
                                  18                         cycle costs to inform planning, budgeting, and
                                  19                         anticipated needs within the continuum of the
                                  20                         medical countermeasure enterprise consistent
                                  21                         with section 319F–2; and
                                  22                                  ‘‘(D) be made available to the appropriate
                                  23                         committees of Congress upon request.’’;
                                  24                         (2) by striking subsection (c) and inserting the




                                  25               following:
                                              •S 242 IS

                                                                                         12
                                    1              ‘‘(c) FUNCTIONS.—The Assistant Secretary for Pre-
                                    2 paredness and Response shall—
                                    3                        ‘‘(1) have lead responsibility within the Depart-
                                    4              ment of Health and Human Services for emergency
                                    5              preparedness and response policy coordination and
                                    6              strategic direction;
                                    7                        ‘‘(2) have authority over and responsibility
                                    8              for—
                                    9                                 ‘‘(A) the National Disaster Medical System
                                  10                         pursuant to section 2812;
                                  11                                  ‘‘(B) the Hospital Preparedness Coopera-
                                  12                         tive Agreement Program pursuant to section
                                  13                         319C–2;
                                  14                                  ‘‘(C) the Biomedical Advanced Research
                                  15                         and Development Authority pursuant to section
                                  16                         319L;
                                  17                                  ‘‘(D) the Medical Reserve Corps pursuant
                                  18                         to section 2813;
                                  19                                  ‘‘(E) the Emergency System for Advance
                                  20                         Registration of Volunteer Health Professionals
                                  21                         pursuant to section 319I; and
                                  22                                  ‘‘(F) administering grants and related au-
                                  23                         thorities related to trauma care under parts A
                                  24                         through C of title XII, such authority to be




                                  25                         transferred by the Secretary from the Adminis-
                                              •S 242 IS

                                                                                         13
                                    1                        trator of the Health Resources and Services Ad-
                                    2                        ministration to such Assistant Secretary;
                                    3                        ‘‘(3) exercise the responsibilities and authorities
                                    4              of the Secretary with respect to the coordination
                                    5              of—
                                    6                                 ‘‘(A) the Public Health Emergency Pre-
                                    7                        paredness Cooperative Agreement Program pur-
                                    8                        suant to section 319C–1;
                                    9                                 ‘‘(B) the Strategic National Stockpile pur-
                                  10                         suant to section 319F–2; and
                                  11                                  ‘‘(C) the Cities Readiness Initiative; and
                                  12                         ‘‘(4) assume other duties as determined appro-
                                  13               priate by the Secretary.’’; and
                                  14                         (3) by adding at the end the following:
                                  15               ‘‘(d) PUBLIC HEALTH EMERGENCY MEDICAL COUN-
                                  16      TERMEASURES                  ENTERPRISE STRATEGY                             AND         IMPLEMEN-
                                  17      TATION           PLAN.—
                                  18                         ‘‘(1) IN        GENERAL.—Not                     later than 180 days
                                  19               after the date of enactment of this subsection, and
                                  20               every year thereafter, the Assistant Secretary for
                                  21               Preparedness and Response shall develop and submit
                                  22               to the appropriate committees of Congress a coordi-
                                  23               nated strategy and accompanying implementation
                                  24               plan for medical countermeasures to address chem-




                                  25               ical, biological, radiological, and nuclear threats. In
                                              •S 242 IS

                                                                                         14
                                    1              developing such a plan, the Assistant Secretary for
                                    2              Preparedness and Response shall consult with the
                                    3              Director of the Biomedical Advanced Research and
                                    4              Development Authority, the Director of the National
                                    5              Institutes of Health, the Director of the Centers for
                                    6              Disease Control and Prevention, and the Commis-
                                    7              sioner of Food and Drugs. Such strategy and plan
                                    8              shall be known as the ‘Public Health Emergency
                                    9              Medical Countermeasures Enterprise Strategy and
                                  10               Implementation Plan’.
                                  11                         ‘‘(2) REQUIREMENTS.—The plan under para-
                                  12               graph (1) shall—
                                  13                                  ‘‘(A) describe the chemical, biological, radi-
                                  14                         ological, and nuclear agent or agents that may
                                  15                         present a threat to the Nation and the cor-
                                  16                         responding efforts to develop qualified counter-
                                  17                         measures (as defined in section 319F–1), secu-
                                  18                         rity countermeasures (as defined in section
                                  19                         319F–2), or qualified pandemic or epidemic
                                  20                         products (as defined in section 319F–3) for
                                  21                         each threat;
                                  22                                  ‘‘(B) evaluate the progress of all activities
                                  23                         with respect to such countermeasures or prod-
                                  24                         ucts, including research, advanced research, de-





                                              •S 242 IS

                                                                                         15
                                    1                        velopment, procurement, stockpiling, deploy-
                                    2                        ment, distribution, and utilization;
                                    3                                 ‘‘(C) identify and prioritize near-, mid-,
                                    4                        and long-term needs with respect to such coun-
                                    5                        termeasures or products to address a chemical,
                                    6                        biological, radiological, and nuclear threat or
                                    7                        threats;
                                    8                                 ‘‘(D) identify, with respect to each cat-
                                    9                        egory of threat, a summary of all awards and
                                  10                         contracts, including advanced research and de-
                                  11                         velopment and procurement, that includes—
                                  12                                         ‘‘(i)       the       time          elapsed           from   the
                                  13                                  issuance of the initial solicitation or re-
                                  14                                  quest for a proposal to the adjudication
                                  15                                  (such as the award, denial of award, or so-
                                  16                                  licitation termination); and
                                  17                                         ‘‘(ii) an identification of projected
                                  18                                  timelines, anticipated funding allocations,
                                  19                                  benchmarks, and milestones for each med-
                                  20                                  ical countermeasure priority under sub-
                                  21                                  paragraph (C), including projected needs
                                  22                                  with regard to replenishment of the Stra-
                                  23                                  tegic National Stockpile;





                                              •S 242 IS

                                                                                         16
                                    1                                 ‘‘(E) be informed by the recommendations
                                    2                        of the National Biodefense Science Board pur-
                                    3                        suant to section 319M;
                                    4                                 ‘‘(F) evaluate progress made in meeting
                                    5                        timelines, allocations, benchmarks, and mile-
                                    6                        stones identified under subparagraph (D)(ii);
                                    7                                 ‘‘(G) report on the amount of funds avail-
                                    8                        able for procurement in the special reserve fund
                                    9                        as defined in section 319F–2(h) and the impact
                                  10                         this funding will have on meeting the require-
                                  11                         ments under section 319F–2;
                                  12                                  ‘‘(H) incorporate input from Federal,
                                  13                         State, local, and tribal stakeholders;
                                  14                                  ‘‘(I) identify the progress made in meeting
                                  15                         the medical countermeasure priorities for at-
                                  16                         risk individuals (as defined in 2802(b)(4)(B)),
                                  17                         as applicable under subparagraph (C), including
                                  18                         with regard to the projected needs for related
                                  19                         stockpiling and replenishment of the Strategic
                                  20                         National Stockpile, including by addressing the
                                  21                         needs of pediatric populations with respect to
                                  22                         such countermeasures and products in the Stra-
                                  23                         tegic National Stockpile, including—





                                              •S 242 IS

                                                                                         17
                                    1                                        ‘‘(i) a list of such countermeasures
                                    2                                 and products necessary to address the
                                    3                                 needs of pediatric populations;
                                    4                                        ‘‘(ii) a description of measures taken
                                    5                                 to coordinate with the Office of Pediatric
                                    6                                 Therapeutics of the Food and Drug Ad-
                                    7                                 ministration to maximize the labeling, dos-
                                    8                                 ages, and formulations of such counter-
                                    9                                 measures and products for pediatric popu-
                                  10                                  lations;
                                  11                                         ‘‘(iii) a description of existing gaps in
                                  12                                  the Strategic National Stockpile and the
                                  13                                  development of such countermeasures and
                                  14                                  products to address the needs of pediatric
                                  15                                  populations; and
                                  16                                         ‘‘(iv) an evaluation of the progress
                                  17                                  made in addressing priorities identified
                                  18                                  pursuant to subparagraph (C);
                                  19                                  ‘‘(J) identify the use of authority and ac-
                                  20                         tivities undertaken pursuant to sections 319F–
                                  21                         1(b)(1), 319F–1(b)(2), 319F–1(b)(3), 319F–
                                  22                         1(c),           319F–1(d),                     319F–1(e),             319F–
                                  23                         2(c)(7)(C)(iii), 319F–2(c)(7)(C)(iv), and 319F–
                                  24                         2(c)(7)(C)(v) of this Act, and subsections





                                  25                         (a)(1), (b)(1), and (e) of section 564 of the


                                              •S 242 IS

                                                                                         18
                                    1                        Federal Food, Drug, and Cosmetic Act, by
                                    2                        summarizing—
                                    3                                        ‘‘(i) the particular actions that were
                                    4                                 taken under the authorities specified, in-
                                    5                                 cluding, as applicable, the identification of
                                    6                                 the threat agent, emergency, or the bio-
                                    7                                 medical countermeasure with respect to
                                    8                                 which the authority was used;
                                    9                                        ‘‘(ii) the reasons underlying the deci-
                                  10                                  sion to use such authorities, including, as
                                  11                                  applicable, the options that were consid-
                                  12                                  ered and rejected with respect to the use of
                                  13                                  such authorities;
                                  14                                         ‘‘(iii) the number of, nature of, and
                                  15                                  other information concerning the persons
                                  16                                  and entities that received a grant, coopera-
                                  17                                  tive agreement, or contract pursuant to the
                                  18                                  use of such authorities, and the persons
                                  19                                  and entities that were considered and re-
                                  20                                  jected for such a grant, cooperative agree-
                                  21                                  ment, or contract, except that the report
                                  22                                  need not disclose the identity of any such
                                  23                                  person or entity;
                                  24                                         ‘‘(iv) whether, with respect to each




                                  25                                  procurement that is approved by the Presi-
                                              •S 242 IS

                                                                                         19
                                    1                                 dent under section 319F–2(c)(6), a con-
                                    2                                 tract was entered into within one year
                                    3                                 after such approval by the President; and
                                    4                                        ‘‘(v) with respect to section 319F–
                                    5                                 1(d), for the one-year period for which the
                                    6                                 report is submitted, the number of persons
                                    7                                 who were paid amounts totaling $100,000
                                    8                                 or greater and the number of persons who
                                    9                                 were        paid        amounts              totaling        at   least
                                  10                                  $50,000 but less than $100,000; and
                                  11                                  ‘‘(K) be made publicly available.
                                  12                         ‘‘(3) GAO            REPORT.—

                                  13                                  ‘‘(A) IN       GENERAL.—Not                    later than 1 year
                                  14                         after the date of the submission to the Congress
                                  15                         of the first Public Health Emergency Medical
                                  16                         Countermeasures Enterprise Strategy and Im-
                                  17                         plementation Plan, the Comptroller General of
                                  18                         the United States shall conduct an independent
                                  19                         evaluation, and submit to the appropriate com-
                                  20                         mittees of Congress a report, concerning such
                                  21                         Strategy and Implementation Plan.
                                  22                                  ‘‘(B) CONTENT.—The report described in
                                  23                         subparagraph (A) shall review and assess—
                                  24                                         ‘‘(i) the near-term, mid-term, and




                                  25                                  long-term medical countermeasure needs
                                              •S 242 IS

                                                                                         20
                                    1                                 and identified priorities of the Federal
                                    2                                 Government pursuant to paragraph (2)(C);
                                    3                                        ‘‘(ii) the activities of the Department
                                    4                                 of Health and Human Services with re-
                                    5                                 spect to advanced research and develop-
                                    6                                 ment pursuant to section 319L; and
                                    7                                        ‘‘(iii) the progress made toward meet-
                                    8                                 ing the timelines, allocations, benchmarks,
                                    9                                 and milestones identified in the Public
                                  10                                  Health           Emergency                  Medical          Counter-
                                  11                                  measures Enterprise Strategy and Imple-
                                  12                                  mentation Plan under this subsection.
                                  13               ‘‘(e) PROTECTION                  OF      NATIONAL SECURITY.—In car-
                                  14 rying out subsections (b)(7) and (d), the Secretary shall
                                  15 ensure that information and items that could compromise
                                  16 national security, contain confidential commercial infor-
                                  17 mation, or contain proprietary information are not dis-
                                  18 closed.’’.
                                  19               (b) INTERAGENCY COORDINATION PLAN.—In the
                                  20 first Public Health Emergency Countermeasures Enter-
                                  21 prise Strategy and Implementation Plan submitted under
                                  22 subsection (d) of section 2811 of the Public Health Service
                                  23 Act (42 U.S.C. 300hh–10) (as added by subsection
                                  24 (a)(3)), the Secretary of Health and Human Services, in




                                  25 consultation with the Secretary of Defense, shall include
                                              •S 242 IS

                                                                                         21
                                    1 a description of the manner in which the Department of
                                    2 Health and Human Services is coordinating with the De-
                                    3 partment of Defense regarding countermeasure activities
                                    4 to address chemical, biological, radiological, and nuclear
                                    5 threats. Such report shall include information with respect
                                    6 to—
                                    7                        (1) the research, advanced research, develop-
                                    8              ment, procurement, stockpiling, and distribution of
                                    9              countermeasures to meet identified needs; and
                                  10                         (2) the coordination of efforts between the De-
                                  11               partment of Health and Human Services and the
                                  12               Department of Defense to address countermeasure
                                  13               needs for various segments of the population.
                                  14      SEC. 103. NATIONAL ADVISORY COMMITTEE ON CHILDREN
                                  15                              AND DISASTERS.
                                  16               Subtitle B of title XXVIII of the Public Health Serv-
                                  17 ice Act (42 U.S.C. 300hh et seq.) is amended by inserting
                                  18 after section 2811 the following:
                                  19      ‘‘SEC. 2811A. NATIONAL ADVISORY COMMITTEE ON CHIL-
                                  20                              DREN AND DISASTERS.
                                  21               ‘‘(a) ESTABLISHMENT.—The Secretary, in consulta-
                                  22 tion with the Secretary of Homeland Security, shall estab-
                                  23 lish an advisory committee to be known as the ‘National
                                  24 Advisory Committee on Children and Disasters’ (referred




                                  25 to in this section as the ‘Advisory Committee’).
                                              •S 242 IS

                                                                                         22
                                    1              ‘‘(b) DUTIES.—The Advisory Committee shall—
                                    2                        ‘‘(1) provide advice and consultation with re-
                                    3              spect to the activities carried out pursuant to section
                                    4              2814, as applicable and appropriate;
                                    5                        ‘‘(2) evaluate and provide input with respect to
                                    6              the medical and public health needs of children as
                                    7              they relate to preparation for, response to, and re-
                                    8              covery from all-hazards emergencies; and
                                    9                        ‘‘(3) provide advice and consultation with re-
                                  10               spect to State emergency preparedness and response
                                  11               activities and children, including related drills and
                                  12               exercises pursuant to the preparedness goals under
                                  13               section 2802(b).
                                  14               ‘‘(c) ADDITIONAL DUTIES.—The Advisory Committee
                                  15 may provide advice and recommendations to the Secretary
                                  16 with respect to children and the medical and public health
                                  17 grants and cooperative agreements as applicable to pre-
                                  18 paredness and response activities authorized under this
                                  19 title and title III.
                                  20               ‘‘(d) MEMBERSHIP.—
                                  21                         ‘‘(1) IN      GENERAL.—The                     Secretary, in consulta-
                                  22               tion with such other Secretaries as may be appro-
                                  23               priate, shall appoint not to exceed 15 members to
                                  24               the Advisory Committee. In appointing such mem-




                                  25               bers, the Secretary shall ensure that the total mem-
                                              •S 242 IS

                                                                                         23
                                    1              bership of the Advisory Committee is an odd num-
                                    2              ber.
                                    3                        ‘‘(2) REQUIRED                  MEMBERS.—The                     Secretary, in
                                    4              consultation with such other Secretaries as may be
                                    5              appropriate, may appoint to the Advisory Committee
                                    6              under paragraph (1) such individuals as may be ap-
                                    7              propriate to perform the duties described in sub-
                                    8              sections (b) and (c), which may include—
                                    9                                 ‘‘(A) the Assistant Secretary for Prepared-
                                  10                         ness and Response;
                                  11                                  ‘‘(B) the Director of the Biomedical Ad-
                                  12                         vanced Research and Development Authority;
                                  13                                  ‘‘(C) the Director of the Centers for Dis-
                                  14                         ease Control and Prevention;
                                  15                                  ‘‘(D) the Commissioner of Food and
                                  16                         Drugs;
                                  17                                  ‘‘(E) the Director of the National Insti-
                                  18                         tutes of Health;
                                  19                                  ‘‘(F) the Assistant Secretary of the Admin-
                                  20                         istration for Children and Families;
                                  21                                  ‘‘(G) the Administrator of the Federal
                                  22                         Emergency Management Agency;
                                  23                                  ‘‘(H) at least two non-Federal health care
                                  24                         professionals with expertise in pediatric medical





                                              •S 242 IS

                                                                                         24
                                    1                        disaster planning, preparedness, response, or
                                    2                        recovery;
                                    3                                 ‘‘(I) at least two representatives from
                                    4                        State, local, territorial, or tribal agencies with
                                    5                        expertise in pediatric disaster planning, pre-
                                    6                        paredness, response, or recovery; and
                                    7                                 ‘‘(J) representatives from such Federal
                                    8                        agencies (such as the Department of Education
                                    9                        and the Department of Homeland Security) as
                                  10                         determined necessary to fulfill the duties of the
                                  11                         Advisory Committee, as established under sub-
                                  12                         sections (b) and (c).
                                  13               ‘‘(e) MEETINGS.—The Advisory Committee shall
                                  14 meet not less than biannually.
                                  15               ‘‘(f) SUNSET.—The Advisory Committee shall termi-
                                  16 nate on September 30, 2018.’’.
                                  17      SEC. 104. MODERNIZATION OF THE NATIONAL DISASTER
                                  18                              MEDICAL SYSTEM.
                                  19               Section 2812 of the Public Health Service Act (42
                                  20 U.S.C. 300hh–11) is amended—
                                  21                         (1) in subsection (a)(3)—
                                  22                                  (A) in subparagraph (A), in clause (i) by
                                  23                         inserting ‘‘, including at-risk individuals as ap-
                                  24                         plicable’’ after ‘‘victims of a public health emer-




                                  25                         gency’’;
                                              •S 242 IS

                                                                                         25
                                    1                                 (B) by redesignating subparagraph (C) as
                                    2                        subparagraph (E); and
                                    3                                 (C) by inserting after subparagraph (B),
                                    4                        the following:
                                    5                                 ‘‘(C) CONSIDERATIONS                       FOR AT-RISK POPU-
                                    6                        LATIONS.—The                    Secretary shall take steps to
                                    7                        ensure that an appropriate specialized and fo-
                                    8                        cused range of public health and medical capa-
                                    9                        bilities are represented in the National Disaster
                                  10                         Medical System, which take into account the
                                  11                         needs of at-risk individuals, in the event of a
                                  12                         public health emergency.’’.
                                  13                                  ‘‘(D)        ADMINISTRATION.—The                             Secretary
                                  14                         may determine and pay claims for reimburse-
                                  15                         ment for services under subparagraph (A) di-
                                  16                         rectly or through contracts that provide for
                                  17                         payment in advance or by way of reimburse-
                                  18                         ment.’’; and
                                  19                         (2) in subsection (g), by striking ‘‘such sums as
                                  20               may be necessary for each of the fiscal years 2007
                                  21               through 2011’’ and inserting ‘‘$52,700,000 for each
                                  22               of fiscal years 2014 through 2018’’.





                                              •S 242 IS

                                                                                         26
                                    1     SEC. 105. CONTINUING THE ROLE OF THE DEPARTMENT OF
                                    2                             VETERANS AFFAIRS.
                                    3              Section 8117(g) of title 38, United States Code, is
                                    4 amended by striking ‘‘such sums as may be necessary to
                                    5 carry out this section for each of fiscal years 2007 through
                                    6 2011’’ and inserting ‘‘$155,300,000 for each of fiscal
                                    7 years 2014 through 2018 to carry out this section’’.
                                    8     TITLE II—OPTIMIZING STATE
                                    9        AND LOCAL ALL-HAZARDS
                                  10         PREPAREDNESS   AND RE-
                                  11         SPONSE
                                  12      SEC. 201. TEMPORARY REASSIGNMENT OF STATE AND
                                  13                              LOCAL            PERSONNEL                  DURING               A   PUBLIC
                                  14                              HEALTH EMERGENCY.
                                  15               Section 319 of the Public Health Service Act (42
                                  16 U.S.C. 247d) is amended by adding at the end the fol-
                                  17 lowing:
                                  18               ‘‘(e) TEMPORARY REASSIGNMENT                                        OF      STATE     AND
                                  19 LOCAL PERSONNEL DURING                                       A      PUBLIC HEALTH EMER-
                                  20      GENCY.—

                                  21                         ‘‘(1) EMERGENCY                     REASSIGNMENT OF FEDER-
                                  22               ALLY FUNDED PERSONNEL.—Notwithstanding                                                 any
                                  23               other provision of law, and subject to paragraph (2),
                                  24               upon request by the Governor of a State or a tribal




                                  25               organization or such Governor or tribal organiza-
                                  26               tion’s designee, the Secretary may authorize the re-
                                              •S 242 IS

                                                                                         27
                                    1              questing State or Indian tribe to temporarily reas-
                                    2              sign, for purposes of immediately addressing a pub-
                                    3              lic health emergency in the State or Indian tribe,
                                    4              State and local public health department or agency
                                    5              personnel funded in whole or in part through pro-
                                    6              grams authorized under this Act, as appropriate.
                                    7                        ‘‘(2) ACTIVATION                   OF EMERGENCY REASSIGN-
                                    8              MENT.—
                                    9                                 ‘‘(A) PUBLIC              HEALTH EMERGENCY.—The
                                  10                         Secretary may authorize a temporary reassign-
                                  11                         ment of personnel under paragraph (1) only
                                  12                         during the period of a public health emergency
                                  13                         determined pursuant to subsection (a).
                                  14                                  ‘‘(B) CONTENTS                     OF REQUEST.—To            seek
                                  15                         authority for a temporary reassignment of per-
                                  16                         sonnel under paragraph (1), the Governor of a
                                  17                         State or a tribal organization shall submit to
                                  18                         the Secretary a request for such reassignment
                                  19                         flexibility and shall include in the request each
                                  20                         of the following:
                                  21                                         ‘‘(i) An assurance that the public
                                  22                                  health emergency in the geographic area of
                                  23                                  the requesting State or Indian tribe cannot
                                  24                                  be adequately and appropriately addressed





                                              •S 242 IS

                                                                                         28
                                    1                                 by the public health workforce otherwise
                                    2                                 available.
                                    3                                        ‘‘(ii) An assurance that the public
                                    4                                 health emergency would be addressed more
                                    5                                 efficiently and effectively through the re-
                                    6                                 quested temporary reassignment of State
                                    7                                 and local personnel described in paragraph
                                    8                                 (1).
                                    9                                        ‘‘(iii) An assurance that the requested
                                  10                                  temporary reassignment of personnel is
                                  11                                  consistent with any applicable All-Hazards
                                  12                                  Public Health Emergency Preparedness
                                  13                                  and Response Plan under section 319C–1.
                                  14                                         ‘‘(iv) An identification of—
                                  15                                                   ‘‘(I) each Federal program from
                                  16                                         which personnel would be temporarily
                                  17                                         reassigned pursuant to the requested
                                  18                                         authority; and
                                  19                                                   ‘‘(II) the number of personnel
                                  20                                         who would be so reassigned from each
                                  21                                         such program.
                                  22                                         ‘‘(v) Such other information and as-
                                  23                                  surances upon which the Secretary and
                                  24                                  Governor of a State or tribal organization




                                  25                                  agree.
                                              •S 242 IS

                                                                                         29
                                    1                                 ‘‘(C) CONSIDERATION.—In reviewing a re-
                                    2                        quest for temporary reassignment under para-
                                    3                        graph (1), the Secretary shall consider the de-
                                    4                        gree to which the program or programs funded
                                    5                        in whole or in part by programs authorized
                                    6                        under this Act would be adversely affected by
                                    7                        the reassignment.
                                    8                                 ‘‘(D) TERMINATION                    AND EXTENSION.—

                                    9                                        ‘‘(i) TERMINATION.—A State or In-
                                  10                                  dian tribe’s temporary reassignment of
                                  11                                  personnel under paragraph (1) shall termi-
                                  12                                  nate upon the earlier of the following:
                                  13                                                   ‘‘(I) The Secretary’s determina-
                                  14                                         tion that the public health emergency
                                  15                                         no longer exists.
                                  16                                                   ‘‘(II) Subject to clause (ii), the
                                  17                                         expiration of the 30-day period fol-
                                  18                                         lowing the date on which the Sec-
                                  19                                         retary approved the State or Indian
                                  20                                         tribe’s request for such reassignment
                                  21                                         flexibility.
                                  22                                         ‘‘(ii) EXTENSION                     OF REASSIGNMENT
                                  23                                  FLEXIBILITY.—The                      Secretary may extend
                                  24                                  a temporary reassignment of personnel




                                  25                                  under paragraph (1) beyond the date oth-
                                              •S 242 IS

                                                                                         30
                                    1                                 erwise applicable under clause (i)(II) if the
                                    2                                 public health emergency still exists as of
                                    3                                 such date, but only if—
                                    4                                                  ‘‘(I) the State or Indian tribe
                                    5                                        that submitted the initial request for
                                    6                                        a temporary reassignment of per-
                                    7                                        sonnel submits a request for an exten-
                                    8                                        sion of such temporary reassignment;
                                  109                                        and       ‘‘(II) the request for an extension
                                  11                                         contains the same information and as-
                                  12                                         surances necessary for the approval of
                                  13                                         an initial request for such temporary
                                  14                                         reassignment pursuant to subpara-
                                  15                                         graph (B).
                                  16                         ‘‘(3) VOLUNTARY                   NATURE OF TEMPORARY RE-
                                  17               ASSIGNMENT OF STATE AND LOCAL PERSONNEL.—
                                  18                                  ‘‘(A) IN       GENERAL.—Unless                        otherwise pro-
                                  19                         vided under the law of the State or Indian tribe
                                  20                         that receives authorization for temporary reas-
                                  21                         signment of personnel under paragraph (1),
                                  22                         personnel eligible for reassignment pursuant to
                                  23                         such authorization—
                                  24                                         ‘‘(i) shall have the opportunity to vol-




                                  25                                  unteer for temporary reassignment; and
                                              •S 242 IS

                                                                                         31
                                    1                                         ‘‘(ii) shall not be required to agree to
                                    2                                 a temporary reassignment.
                                    3                                 ‘‘(B)        PROHIBITION                   ON         CONDITIONING
                                    4                        FEDERAL AWARDS.—The                                Secretary may not
                                    5                        condition the award of a grant, contract, or co-
                                    6                        operative agreement under this Act on the re-
                                    7                        quirement that a State or Indian tribe require
                                    8                        that personnel eligible for reassignment pursu-
                                    9                        ant to an authorization under paragraph (1)
                                  10                         agree to such reassignment.
                                  11                         ‘‘(4) NOTICE               TO CONGRESS.—The                           Secretary
                                  12               shall give notice to the Congress in conjunction with
                                  13               the approval under this subsection of—
                                  14                                  ‘‘(A) any initial request for temporary re-
                                  15                         assignment of personnel; and
                                  16                                  ‘‘(B) any request for an extension of such
                                  17                         temporary reassignment.
                                  18                         ‘‘(5) GUIDANCE.—The Secretary shall—
                                  19                                  ‘‘(A) not later than 6 months after the en-
                                  20                         actment of this subsection, issue proposed guid-
                                  21                         ance on the temporary reassignment of per-
                                  22                         sonnel under this subsection; and
                                  23                                  ‘‘(B) after providing notice and a 60-day
                                  24                         period for public comment, finalize such guid-




                                  25                         ance.
                                              •S 242 IS

                                                                                         32
                                    1                        ‘‘(6) REPORT             TO CONGRESS.—Not                         later than 4
                                    2              years after the date of enactment of the Pandemic
                                    3              and All-Hazards Preparedness Reauthorization Act
                                    4              of 2013, the Comptroller General of the United
                                    5              States shall conduct an independent evaluation, and
                                    6              submit to the appropriate committees of the Con-
                                    7              gress a report, on temporary reassignment under
                                    8              this subsection, including—
                                    9                                 ‘‘(A) a description of how, and under what
                                  10                         circumstances, such temporary reassignment
                                  11                         has been used by States and Indian tribes;
                                  12                                  ‘‘(B) an analysis of how such temporary
                                  13                         reassignment has assisted States and Indian
                                  14                         tribes in responding to public health emer-
                                  15                         gencies;
                                  16                                  ‘‘(C) an evaluation of how such temporary
                                  17                         reassignment has improved operational effi-
                                  18                         ciencies in responding to public health emer-
                                  19                         gencies;
                                  20                                  ‘‘(D) an analysis of the extent to which, if
                                  21                         any, Federal programs from which personnel
                                  22                         have been temporarily reassigned have been ad-
                                  23                         versely affected by the reassignment; and
                                  24                                  ‘‘(E) recommendations on how medical




                                  25                         surge capacity could be improved in responding
                                              •S 242 IS

                                                                                         33
                                    1                        to public health emergencies and the impact of
                                    2                        the reassignment flexibility under this section
                                    3                        on such surge capacity.
                                    4                        ‘‘(7) DEFINITIONS.—In this subsection—
                                    5                                 ‘‘(A) the terms ‘Indian tribe’ and ‘tribal
                                    6                        organization’ have the meanings given such
                                    7                        terms in section 4 of the Indian Self-Deter-
                                    8                        mination and Education Assistance Act; and
                                    9                                 ‘‘(B) the term ‘State’ includes, in addition
                                  10                         to the entities listed in the definition of such
                                  11                         term in section 2, the Freely Associated States.
                                  12                         ‘‘(8) SUNSET.—This subsection shall terminate
                                  13               on September 30, 2018.’’.
                                  14      SEC. 202. IMPROVING STATE AND LOCAL PUBLIC HEALTH
                                  15                              SECURITY.
                                  16               (a) COOPERATIVE AGREEMENTS.—Section 319C–1
                                  17 of the Public Health Service Act (42 U.S.C. 247d–3a) is
                                  18 amended—
                                  19                         (1) in subsection (b)(1)(C), by striking ‘‘consor-
                                  20               tium of entities described in subparagraph (A)’’ and
                                  21               inserting ‘‘consortium of States’’;
                                  22                         (2) in subsection (b)(2)—
                                  23                                  (A) in subparagraph (A)—
                                  24                                         (i) by striking clauses (i) and (ii) and




                                  25                                  inserting the following:
                                              •S 242 IS

                                                                                         34
                                    1                                        ‘‘(i) a description of the activities such
                                    2                                 entity will carry out under the agreement
                                    3                                 to meet the goals identified under section
                                    4                                 2802, including with respect to chemical,
                                    5                                 biological, radiological, or nuclear threats,
                                    6                                 whether naturally occurring, unintentional,
                                    7                                 or deliberate;
                                    8                                        ‘‘(ii) a description of the activities
                                    9                                 such entity will carry out with respect to
                                  10                                  pandemic influenza, as a component of the
                                  11                                  activities carried out under clause (i), and
                                  12                                  consistent with the requirements of para-
                                  13                                  graphs (2) and (5) of subsection (g);’’;
                                  14                                         (ii) in clause (iv), by striking ‘‘and’’ at
                                  15                                  the end; and
                                  16                                         (iii) by adding at the end the fol-
                                  17                                  lowing:
                                  18                                         ‘‘(vi) a description of how, as appro-
                                  19                                  priate, the entity may partner with rel-
                                  20                                  evant public and private stakeholders in
                                  21                                  public health emergency preparedness and
                                  22                                  response;
                                  23                                         ‘‘(vii) a description of how the entity,
                                  24                                  as applicable and appropriate, will coordi-




                                  25                                  nate with State emergency preparedness
                                              •S 242 IS

                                                                                         35
                                    1                                 and response plans in public health emer-
                                    2                                 gency preparedness, including State edu-
                                    3                                 cational agencies (as defined in section
                                    4                                 9101(41) of the Elementary and Sec-
                                    5                                 ondary Education Act of 1965) and State
                                    6                                 child care lead agencies (designated under
                                    7                                 section 658D of the Child Care and Devel-
                                    8                                 opment Block Grant Act of 1990);
                                    9                                        ‘‘(viii) in the case of entities that op-
                                  10                                  erate on the United States-Mexico border
                                  11                                  or the United States-Canada border, a de-
                                  12                                  scription of the activities such entity will
                                  13                                  carry out under the agreement that are
                                  14                                  specific to the border area including dis-
                                  15                                  ease detection, identification, investigation,
                                  16                                  and preparedness and response activities
                                  17                                  related to emerging diseases and infectious
                                  18                                  disease outbreaks whether naturally occur-
                                  19                                  ring or due to bioterrorism, consistent with
                                  20                                  the requirements of this section; and
                                  21                                         ‘‘(ix) a description of any activities
                                  22                                  that such entity will use to analyze real-
                                  23                                  time clinical specimens for pathogens of
                                  24                                  public health or bioterrorism significance,





                                              •S 242 IS

                                                                                         36
                                    1                                 including any utilization of poison control
                                    2                                 centers;’’; and
                                    3                                 (B) in subparagraph (C), by inserting ‘‘,
                                    4                        including addressing the needs of at-risk indi-
                                    5                        viduals,’’ after ‘‘capabilities of such entity’’;
                                    6                        (3) in subsection (f)—
                                    7                                 (A) in paragraph (2), by adding ‘‘and’’ at
                                    8                        the end;
                                    9                                 (B) in paragraph (3), by striking ‘‘; and’’
                                  10                         and inserting a period; and
                                  11                                  (C) by striking paragraph (4);
                                  12                         (4) in subsection (g)—
                                  13                                  (A) in paragraph (1), by striking subpara-
                                  14                         graph (A) and inserting the following:
                                  15                                  ‘‘(A) include outcome goals representing
                                  16                         operational achievements of the National Pre-
                                  17                         paredness             Goals          developed                 under   section
                                  18                         2802(b) with respect to all-hazards, including
                                  19                         chemical, biological, radiological, or nuclear
                                  20                         threats; and’’; and
                                  21                                  (B) in paragraph (2)(A), by adding at the
                                  22                         end the following: ‘‘The Secretary shall periodi-
                                  23                         cally update, as necessary and appropriate,
                                  24                         such pandemic influenza plan criteria and shall




                                  25                         require the integration of such criteria into the
                                              •S 242 IS

                                                                                         37
                                    1                        benchmarks and standards described in para-
                                    2                        graph (1).’’;
                                    3                        (5) by striking subsection (h);
                                    4                        (6) by redesignating subsections (i), (j), and (k)
                                    5              as subsections (h), (i), and (j), respectively;
                                    6                        (7) in subsection (h), as so redesignated—
                                    7                                 (A) in paragraph (1)—
                                    8                                        (i) in subparagraph (A)—
                                    9                                                  (I) by striking ‘‘$824,000,000 for
                                  10                                         fiscal            year            2007,               of   which
                                  11                                         $35,000,000 shall be used to carry
                                  12                                         out subsection (h),’’ and inserting
                                  13                                         ‘‘$641,900,000 for fiscal year 2014’’;
                                  14                                         and
                                  15                                                   (II) by striking ‘‘such sums as
                                  16                                         may be necessary for each of fiscal
                                  17                                         years 2008 through 2011’’ and insert-
                                  18                                         ing ‘‘$641,900,000 for each of fiscal
                                  19                                         years 2015 through 2018’’;
                                  20                                         (ii) by striking subparagraph (B);
                                  21                                         (iii) by redesignating subparagraphs
                                  22                                  (C) and (D) as subparagraphs (B) and
                                  23                                  (C), respectively; and





                                              •S 242 IS

                                                                                         38
                                    1                                        (iv) in subparagraph (C), as so redes-
                                    2                                 ignated, by striking ‘‘subparagraph (C)’’
                                    3                                 and inserting ‘‘subparagraph (B)’’;
                                    4                                 (B) in subparagraphs (C) and (D) of para-
                                    5                        graph (3), by striking ‘‘(1)(A)(i)(I)’’ each place
                                    6                        it appears and inserting ‘‘(1)(A)’’;
                                    7                                 (C) in paragraph (4)(B), by striking ‘‘sub-
                                    8                        section (c)’’ and inserting ‘‘subsection (b)’’; and
                                    9                                 (D) by adding at the end the following:
                                  10                         ‘‘(7) AVAILABILITY                    OF COOPERATIVE AGREE-
                                  11               MENT FUNDS.—
                                  12                                  ‘‘(A) IN        GENERAL.—Amounts                             provided to
                                  13                         an eligible entity under a cooperative agreement
                                  14                         under subsection (a) for a fiscal year and re-
                                  15                         maining unobligated at the end of such year
                                  16                         shall remain available to such entity for the
                                  17                         next fiscal year for the purposes for which such
                                  18                         funds were provided.
                                  19                                  ‘‘(B) FUNDS              CONTINGENT ON ACHIEVING
                                  20                         BENCHMARKS.—The                         continued availability of
                                  21                         funds under subparagraph (A) with respect to
                                  22                         an entity shall be contingent upon such entity
                                  23                         achieving the benchmarks and submitting the
                                  24                         pandemic influenza plan as described in sub-




                                  25                         section (g).’’; and
                                              •S 242 IS

                                                                                         39
                                    1                        (8) in subsection (i), as so redesignated—
                                    2                                 (A) in paragraph (1)(E), by striking ‘‘sub-
                                    3                        section (k)’’ and inserting ‘‘subsection (j)’’; and
                                    4                                 (B) by striking paragraph (3).
                                    5              (b) VACCINE TRACKING                            AND       DISTRIBUTION.—Sec-
                                    6 tion 319A(e) of the Public Health Service Act (42 U.S.C.
                                    7 247d–1(e)) is amended by striking ‘‘such sums for each
                                    8 of fiscal years 2007 through 2011’’ and inserting
                                    9 ‘‘$30,800,000 for each of fiscal years 2014 through
                                  10 2018’’.
                                  11               (c) TECHNICAL                  AND        CONFORMING AMENDMENTS.—
                                  12                         (1) Section 319C–1(b)(1)(B) of the Public
                                  13               Health Service Act (42 U.S.C. 247d–3a(b)(1)(B)) is
                                  14               amended by striking ‘‘subsection (i)(4)’’ and insert-
                                  15               ing ‘‘subsection (h)(4)’’.
                                  16                         (2) Section 319C–2 of the Public Health Serv-
                                  17               ice Act (42 U.S.C. 247d–3b) is amended—
                                  18                                  (A) in subsection (i), by striking ‘‘(j), and
                                  19                         (k)’’ and inserting ‘‘(i), and (j)’’; and
                                  20                                  (B) in subsection (j)(3), by striking
                                  21                         ‘‘319C–1(i)’’ and inserting ‘‘319C–1(h)’’.
                                  22      SEC. 203. HOSPITAL PREPAREDNESS AND MEDICAL SURGE
                                  23                              CAPACITY.
                                  24               (a) ALL-HAZARDS PUBLIC HEALTH                                            AND    MEDICAL
                                  25 RESPONSE                         CURRICULA                  AND            TRAINING.—Section


                                              •S 242 IS

                                                                                         40
                                    1 319F(a)(5)(B) of the Public Health Service Act (42
                                    2 U.S.C. 247d–6(a)(5)(B)) is amended by striking ‘‘public
                                    3 health or medical’’ and inserting ‘‘public health, medical,
                                    4 or dental’’.
                                    5              (b) ENCOURAGING HEALTH PROFESSIONAL VOLUN-
                                    6     TEERS.—

                                    7                        (1) EMERGENCY                    SYSTEM FOR ADVANCE REG-
                                    8              ISTRATION                OF         VOLUNTEER                  HEALTH           PROFES-
                                    9              SIONALS.—Section                     319I(k) of the Public Health
                                  10               Service Act (42 U.S.C. 247d–7b(k)) is amended by
                                  11               striking ‘‘$2,000,000 for fiscal year 2002, and such
                                  12               sums as may be necessary for each of the fiscal
                                  13               years          2003            through                2011’’             and    inserting
                                  14               ‘‘$5,000,000 for each of fiscal years 2014 through
                                  15               2018’’.
                                  16                         (2) VOLUNTEERS.—Section 2813 of the Public
                                  17               Health Service Act (42 U.S.C. 300hh–15) is amend-
                                  18               ed—
                                  19                                  (A) in subsection (d)(2), by adding at the
                                  20                         end the following: ‘‘Such training exercises
                                  21                         shall, as appropriate and applicable, incorporate
                                  22                         the needs of at-risk individuals in the event of
                                  23                         a public health emergency.’’; and
                                  24                                  (B)         in     subsection                (i),       by    striking





                                  25                         ‘‘$22,000,000 for fiscal year 2007, and such


                                              •S 242 IS

                                                                                         41
                                    1                        sums as may be necessary for each of fiscal
                                    2                        years 2008 through 2011’’ and inserting
                                    3                        ‘‘$11,200,000 for each of fiscal years 2014
                                    4                        through 2018’’.
                                    5              (c) PARTNERSHIPS                    FOR      STATE          AND      REGIONAL PRE-
                                    6     PAREDNESS                   TO IMPROVE SURGE CAPACITY.—Section
                                    7 319C–2 of the Public Health Service Act (42 U.S.C.
                                    8 247d–3b) is amended—
                                    9                        (1) in subsection (a), by inserting ‘‘, including,
                                  10               as appropriate, capacity and preparedness to address
                                  11               the needs of children and other at-risk individuals’’
                                  12               before the period at the end;
                                  13                         (2) in subsection (b)(1)(A)(ii), by striking ‘‘cen-
                                  14               ters, primary’’ and inserting ‘‘centers, community
                                  15               health centers, primary’’;
                                  16                         (3) by striking subsection (c) and inserting the
                                  17               following:
                                  18               ‘‘(c) USE           OF    FUNDS.—An award under subsection
                                  19 (a) shall be expended for activities to achieve the prepared-
                                  20 ness goals described under paragraphs (1), (3), (4), (5),
                                  21 and (6) of section 2802(b) with respect to all-hazards, in-
                                  22 cluding chemical, biological, radiological, or nuclear
                                  23 threats.’’;
                                  24                         (4) by striking subsection (g) and inserting the




                                  25               following:
                                              •S 242 IS

                                    1              ‘‘(g) COORDINATION.—            42
                                    2                        ‘‘(1) LOCAL            RESPONSE CAPABILITIES.—An                      eli-
                                    3              gible entity shall, to the extent practicable, ensure
                                    4              that activities carried out under an award under
                                    5              subsection (a) are coordinated with activities of rel-
                                    6              evant local Metropolitan Medical Response Systems,
                                    7              local Medical Reserve Corps, the local Cities Readi-
                                    8              ness Initiative, and local emergency plans.
                                    9                        ‘‘(2)       NATIONAL                COLLABORATION.—Partner-
                                  10               ships consisting of one or more eligible entities
                                  11               under this section may, to the extent practicable,
                                  12               collaborate with other partnerships consisting of one
                                  13               or more eligible entities under this section for pur-
                                  14               poses of national coordination and collaboration with
                                  15               respect to activities to achieve the preparedness
                                  16               goals described under paragraphs (1), (3), (4), (5),
                                  17               and (6) of section 2802(b).’’;
                                  18                         (5) in subsection (i)—
                                  19                                  (A) by striking ‘‘The requirements of’’ and
                                  20                         inserting the following:
                                  21                         ‘‘(1) IN       GENERAL.—The                    requirements of’’; and
                                  22                                  (B) by adding at the end the following:
                                  23                         ‘‘(2) MEETING                   GOALS OF NATIONAL HEALTH
                                  24               SECURITY STRATEGY.—The                                  Secretary shall imple-




                                  25               ment objective, evidence-based metrics to ensure that
                                              •S 242 IS

                                                                                         43
                                    1              entities receiving awards under this section are
                                    2              meeting, to the extent practicable, the applicable
                                    3              goals of the National Health Security Strategy
                                    4              under section 2802.’’; and
                                    5                        (6) in subsection (j)—
                                    6                                 (A) by amending paragraph (1) to read as
                                    7                        follows:
                                    8                        ‘‘(1) IN        GENERAL.—For                     purposes of carrying
                                    9              out this section, there is authorized to be appro-
                                  10               priated $374,700,000 for each of fiscal years 2014
                                  11               through 2018.’’; and
                                  12                                  (B) by adding at the end the following:
                                  13                         ‘‘(4) AVAILABILITY                    OF COOPERATIVE AGREE-
                                  14               MENT FUNDS.—
                                  15                                  ‘‘(A) IN        GENERAL.—Amounts                             provided to
                                  16                         an eligible entity under a cooperative agreement
                                  17                         under subsection (a) for a fiscal year and re-
                                  18                         maining unobligated at the end of such year
                                  19                         shall remain available to such entity for the
                                  20                         next fiscal year for the purposes for which such
                                  21                         funds were provided.
                                  22                                  ‘‘(B) FUNDS              CONTINGENT ON ACHIEVING
                                  23                         BENCHMARKS.—The                         continued availability of
                                  24                         funds under subparagraph (A) with respect to




                                  25                         an entity shall be contingent upon such entity
                                              •S 242 IS

                                                                                         44
                                    1                        achieving the benchmarks and submitting the
                                    2                        pandemic influenza plan as required under sub-
                                    3                        section (i).’’.
                                    4     SEC. 204. ENHANCING SITUATIONAL AWARENESS AND BIO-
                                    5                             SURVEILLANCE.
                                    6              Section 319D of the Public Health Service Act (42
                                    7 U.S.C. 247d–4) is amended—
                                    8                        (1) in subsection (b)—
                                    9                                 (A) in paragraph (1)(B), by inserting ‘‘poi-
                                  10                         son control centers,’’ after ‘‘hospitals,’’;
                                  11                                  (B) in paragraph (2), by inserting before
                                  12                         the period at the end the following: ‘‘, allowing
                                  13                         for coordination to maximize all-hazards med-
                                  14                         ical and public health preparedness and re-
                                  15                         sponse and to minimize duplication of effort’’;
                                  16                         and
                                  17                                  (C) in paragraph (3), by inserting before
                                  18                         the period at the end the following: ‘‘and up-
                                  19                         date such standards as necessary’’;
                                  20                         (2) by striking subsection (c); and
                                  21                         (3) in subsection (d)—
                                  22                                  (A) in the subsection heading, by striking
                                  23                         ‘‘PUBLIC HEALTH SITUATIONAL AWARENESS’’
                                  24                         and inserting ‘‘MODERNIZING PUBLIC HEALTH





                                              •S 242 IS

                                    1                        SITUATIONAL AWARENESS       45                        AND        BIOSURVEIL-
                                    2                        LANCE’’;

                                    3                                 (B) in paragraph (1)—
                                    4                                        (i) by striking ‘‘Pandemic and All-
                                    5                                 Hazards Preparedness Act’’ and inserting
                                    6                                 ‘‘Pandemic and All-Hazards Preparedness
                                    7                                 Reauthorization Act of 2013’’; and
                                    8                                        (ii) by inserting ‘‘, novel emerging
                                    9                                 threats,’’ after ‘‘disease outbreaks’’;
                                  10                                  (C) by striking paragraph (2) and insert-
                                  11                         ing the following:
                                  12                         ‘‘(2)         STRATEGY                  AND             IMPLEMENTATION
                                  13               PLAN.—Not               later than 180 days after the date of
                                  14               enactment of the Pandemic and All-Hazards Pre-
                                  15               paredness Reauthorization Act of 2013, the Sec-
                                  16               retary shall submit to the appropriate committees of
                                  17               Congress a coordinated strategy and an accom-
                                  18               panying implementation plan that identifies and
                                  19               demonstrates the measurable steps the Secretary will
                                  20               carry out to—
                                  21                                  ‘‘(A) develop, implement, and evaluate the
                                  22                         network described in paragraph (1), utilizing
                                  23                         the elements described in paragraph (3);
                                  24                                  ‘‘(B) modernize and enhance biosurveil-




                                  25                         lance activities; and
                                              •S 242 IS

                                                                                         46
                                    1                                 ‘‘(C) improve information sharing, coordi-
                                    2                        nation, and communication among disparate
                                    3                        biosurveillance systems supported by the De-
                                    4                        partment of Health and Human Services.’’;
                                    5                                 (D) in paragraph (3)(D), by inserting
                                    6                        ‘‘community health centers, health centers’’
                                    7                        after ‘‘poison control,’’;
                                    8                                 (E) in paragraph (5), by striking subpara-
                                    9                        graph (A) and inserting the following:
                                  10                                  ‘‘(A)       utilize         applicable                interoperability
                                  11                         standards as determined by the Secretary, and
                                  12                         in consultation with the Office of the National
                                  13                         Coordinator for Health Information Tech-
                                  14                         nology, through a joint public and private sec-
                                  15                         tor process;’’; and
                                  16                                  (F) by adding at the end the following:
                                  17                         ‘‘(6) CONSULTATION                     WITH THE NATIONAL BIO-
                                  18               DEFENSE SCIENCE BOARD.—In                                        carrying out this
                                  19               section and consistent with section 319M, the Na-
                                  20               tional Biodefense Science Board shall provide expert
                                  21               advice and guidance, including recommendations, re-
                                  22               garding the measurable steps the Secretary should
                                  23               take to modernize and enhance biosurveillance activi-
                                  24               ties pursuant to the efforts of the Department of




                                  25               Health and Human Services to ensure comprehen-
                                              •S 242 IS

                                                                                         47
                                    1              sive, real-time, all-hazards biosurveillance capabili-
                                    2              ties. In complying with the preceding sentence, the
                                    3              National Biodefense Science Board shall—
                                    4                                 ‘‘(A) identify the steps necessary to achieve
                                    5                        a national biosurveillance system for human
                                    6                        health, with international connectivity, where
                                    7                        appropriate, that is predicated on State, re-
                                    8                        gional, and community level capabilities and
                                    9                        creates a networked system to allow for two-
                                  10                         way information flow between and among Fed-
                                  11                         eral, State, and local government public health
                                  12                         authorities and clinical health care providers;
                                  13                                  ‘‘(B) identify any duplicative surveillance
                                  14                         programs under the authority of the Secretary,
                                  15                         or changes that are necessary to existing pro-
                                  16                         grams, in order to enhance and modernize such
                                  17                         activities, minimize duplication, strengthen and
                                  18                         streamline such activities under the authority of
                                  19                         the Secretary, and achieve real-time and appro-
                                  20                         priate data that relate to disease activity, both
                                  21                         human and zoonotic; and
                                  22                                  ‘‘(C) coordinate with applicable existing
                                  23                         advisory committees of the Director of the Cen-
                                  24                         ters for Disease Control and Prevention, includ-




                                  25                         ing such advisory committees consisting of rep-
                                              •S 242 IS

                                                                                         48
                                    1                        resentatives from State, local, and tribal public
                                    2                        health authorities and appropriate public and
                                    3                        private sector health care entities and academic
                                    4                        institutions, in order to provide guidance on
                                    5                        public health surveillance activities.’’;
                                    6                        (4) in subsection (e)(5), by striking ‘‘4 years
                                    7              after the date of enactment of the Pandemic and
                                    8              All-Hazards Preparedness Act’’ and inserting ‘‘3
                                    9              years after the date of enactment of the Pandemic
                                  10               and All-Hazards Preparedness Reauthorization Act
                                  11               of 2013’’;
                                  12                         (5) in subsection (g), by striking ‘‘such sums as
                                  13               may be necessary in each of fiscal years 2007
                                  14               through 2011’’ and inserting ‘‘$138,300,000 for
                                  15               each of fiscal years 2014 through 2018’’; and
                                  16                         (6) by adding at the end the following:
                                  17               ‘‘(h) DEFINITION.—For purposes of this section the
                                  18 term ‘biosurveillance’ means the process of gathering near
                                  19 real-time biological data that relates to human and
                                  20 zoonotic disease activity and threats to human or animal
                                  21 health, in order to achieve early warning and identification
                                  22 of such health threats, early detection and prompt ongoing
                                  23 tracking of health events, and overall situational aware-
                                  24 ness of disease activity.’’.





                                              •S 242 IS

                                                                                         49
                                    1     SEC. 205. ELIMINATING DUPLICATIVE PROJECT BIOSHIELD
                                    2                             REPORTS.
                                    3              Section 5 of the Project Bioshield Act of 2004 (42
                                    4 U.S.C. 247d–6c) is repealed.
                                    5     TITLE III—ENHANCING MEDICAL
                                    6       COUNTERMEASURE REVIEW
                                    7     SEC. 301. SPECIAL PROTOCOL ASSESSMENT.
                                    8              Section 505(b)(5)(B) of the Federal Food, Drug, and
                                    9 Cosmetic Act (21 U.S.C. 355(b)(5)(B)) is amended by
                                  10 striking ‘‘size of clinical trials intended’’ and all that fol-
                                  11 lows through ‘‘. The sponsor or applicant’’ and inserting
                                  12 the following: ‘‘size—
                                  13                         ‘‘(i)(I) of clinical trials intended to form the
                                  14               primary basis of an effectiveness claim; or
                                  15                         ‘‘(II) in the case where human efficacy studies
                                  16               are not ethical or feasible, of animal and any associ-
                                  17               ated clinical trials which, in combination, are in-
                                  18               tended to form the primary basis of an effectiveness
                                  19               claim; or
                                  20                         ‘‘(ii) with respect to an application for approval
                                  21               of a biological product under section 351(k) of the
                                  22               Public Health Service Act, of any necessary clinical
                                  23               study or studies.
                                  24 The sponsor or applicant’’.





                                              •S 242 IS

                                                                                         50
                                    1     SEC. 302. AUTHORIZATION FOR MEDICAL PRODUCTS FOR
                                    2                             USE IN EMERGENCIES.
                                    3              (a) IN GENERAL.—Section 564 of the Federal Food,
                                    4 Drug, and Cosmetic Act (21 U.S.C. 360bbb–3) is amend-
                                    5 ed—
                                    6                        (1) in subsection (a)—
                                    7                                 (A) in paragraph (1), by striking ‘‘sections
                                    8                        505, 510(k), and 515 of this Act’’ and inserting
                                    9                        ‘‘any provision of this Act’’;
                                  10                                  (B) in paragraph (2)(A), by striking
                                  11                         ‘‘under a provision of law referred to in such
                                  12                         paragraph’’ and inserting ‘‘under section 505,
                                  13                         510(k), or 515 of this Act or section 351 of the
                                  14                         Public Health Service Act’’; and
                                  15                                  (C) in paragraph (3), by striking ‘‘a provi-
                                  16                         sion of law referred to in such paragraph’’ and
                                  17                         inserting ‘‘a section of this Act or the Public
                                  18                         Health Service Act referred to in paragraph
                                  19                         (2)(A)’’;
                                  20                         (2) in subsection (b)—
                                  21                                  (A) in the subsection heading, by striking
                                  22                         ‘‘EMERGENCY’’ and inserting ‘‘EMERGENCY                               OR
                                  23                         THREAT JUSTIFYING EMERGENCY AUTHOR-
                                  24                         IZED      USE’’;
                                  25                                  (B) in paragraph (1)—


                                              •S 242 IS

                                                                                         51
                                    1                                        (i) in the matter preceding subpara-
                                    2                                 graph (A), by striking ‘‘may declare an
                                    3                                 emergency’’ and inserting ‘‘may make a
                                    4                                 declaration that the circumstances exist’’;
                                    5                                        (ii) in subparagraph (A), by striking
                                    6                                 ‘‘specified’’;
                                    7                                        (iii) in subparagraph (B)—
                                    8                                                  (I) by striking ‘‘specified’’; and
                                    9                                                  (II) by striking ‘‘; or’’ and insert-
                                  10                                         ing a semicolon;
                                  11                                         (iv) by amending subparagraph (C) to
                                  12                                  read as follows:
                                  13                                  ‘‘(C) a determination by the Secretary that
                                  14                         there is a public health emergency, or a signifi-
                                  15                         cant potential for a public health emergency,
                                  16                         that affects, or has a significant potential to af-
                                  17                         fect, national security or the health and security
                                  18                         of United States citizens living abroad, and that
                                  19                         involves a biological, chemical, radiological, or
                                  20                         nuclear agent or agents, or a disease or condi-
                                  21                         tion that may be attributable to such agent or
                                  22                         agents; or’’; and
                                  23                                         (v) by adding at the end the following:
                                  24                                  ‘‘(D) the identification of a material threat




                                  25                         pursuant to section 319F–2 of the Public
                                              •S 242 IS

                                                                                         52
                                    1                        Health Service Act sufficient to affect national
                                    2                        security or the health and security of United
                                    3                        States citizens living abroad.’’;
                                    4                                 (C) in paragraph (2)—
                                    5                                        (i) in subparagraph (A), by amending
                                    6                                 clause (ii) to read as follows:
                                    7                                        ‘‘(ii) a change in the approval status
                                    8                                 of the product such that the circumstances
                                    9                                 described in subsection (a)(2) have ceased
                                  10                                  to exist.’’;
                                  11                                         (ii) by striking subparagraph (B); and
                                  12                                         (iii) by redesignating subparagraph
                                  13                                  (C) as subparagraph (B);
                                  14                                  (D) in paragraph (4), by striking ‘‘advance
                                  15                         notice of termination, and renewal under this
                                  16                         subsection.’’ and inserting ‘‘, and advance no-
                                  17                         tice of termination under this subsection.’’; and
                                  18                                  (E) by adding at the end the following:
                                  19                         ‘‘(5) EXPLANATION                    BY SECRETARY.—If                 an au-
                                  20               thorization under this section with respect to an un-
                                  21               approved product or an unapproved use of an ap-
                                  22               proved product has been in effect for more than 1
                                  23               year, the Secretary shall provide in writing to the
                                  24               sponsor of such product an explanation of the sci-




                                  25               entific, regulatory, or other obstacles to approval, li-
                                              •S 242 IS

                                                                                         53
                                    1              censure, or clearance of such product or use, includ-
                                    2              ing specific actions to be taken by the Secretary and
                                    3              the sponsor to overcome such obstacles.’’;
                                    4                        (3) in subsection (c)—
                                    5                                 (A) in the matter preceding paragraph
                                    6                        (1)—
                                    7                                        (i) by inserting ‘‘the Assistant Sec-
                                    8                                 retary for Preparedness and Response,’’
                                    9                                 after ‘‘consultation with’’;
                                  10                                         (ii) by striking ‘‘Health and’’ and in-
                                  11                                  serting ‘‘Health, and’’; and
                                  12                                         (iii) by striking ‘‘circumstances of the
                                  13                                  emergency involved’’ and inserting ‘‘appli-
                                  14                                  cable circumstances described in subsection
                                  15                                  (b)(1)’’;
                                  16                                  (B) in paragraph (1), by striking ‘‘speci-
                                  17                         fied’’ and inserting ‘‘referred to’’; and
                                  18                                  (C) in paragraph (2)(B), by inserting ‘‘,
                                  19                         taking into consideration the material threat
                                  20                         posed by the agent or agents identified in a dec-
                                  21                         laration under subsection (b)(1)(D), if applica-
                                  22                         ble’’ after ‘‘risks of the product’’;
                                  23                         (4) in subsection (d)(3), by inserting ‘‘, to the
                                  24               extent practicable given the circumstances of the




                                  25               emergency,’’ after ‘‘including’’;
                                              •S 242 IS

                                                                                         54
                                    1                        (5) in subsection (e)—
                                    2                                 (A) in paragraph (1)(A), by striking ‘‘cir-
                                    3                        cumstances of the emergency’’ and inserting
                                    4                        ‘‘applicable circumstances described in sub-
                                    5                        section (b)(1)’’;
                                    6                                 (B) in paragraph (1)(B), by amending
                                    7                        clause (iii) to read as follows:
                                    8                                        ‘‘(iii) Appropriate conditions with re-
                                    9                                 spect to collection and analysis of informa-
                                  10                                  tion concerning the safety and effectiveness
                                  11                                  of the product with respect to the use of
                                  12                                  such product during the period when the
                                  13                                  authorization is in effect and a reasonable
                                  14                                  time following such period.’’;
                                  15                                  (C) in paragraph (2)—
                                  16                                         (i) in subparagraph (A)—
                                  17                                                   (I) by striking ‘‘manufacturer of
                                  18                                         the product’’ and inserting ‘‘person’’;
                                  19                                                   (II) by striking ‘‘circumstances of
                                  20                                         the emergency’’ and inserting ‘‘appli-
                                  21                                         cable circumstances described in sub-
                                  22                                         section (b)(1)’’; and
                                  23                                                   (III) by inserting at the end be-
                                  24                                         fore the period ‘‘or in paragraph





                                  25                                         (1)(B)’’;


                                              •S 242 IS

                                                                                         55
                                    1                                        (ii) in subparagraph (B)(i), by insert-
                                    2                                 ing before the period at the end ‘‘, except
                                    3                                 as provided in section 564A with respect to
                                    4                                 authorized changes to the product expira-
                                    5                                 tion date’’; and
                                    6                                        (iii) by amending subparagraph (C) to
                                    7                                 read as follows:
                                    8                                 ‘‘(C) In establishing conditions under this
                                    9                        paragraph with respect to the distribution and
                                  10                         administration of the product for the unap-
                                  11                         proved use, the Secretary shall not impose con-
                                  12                         ditions that would restrict distribution or ad-
                                  13                         ministration of the product when distributed or
                                  14                         administered for the approved use.’’; and
                                  15                                  (D) by amending paragraph (3) to read as
                                  16                         follows:
                                  17                         ‘‘(3) GOOD             MANUFACTURING PRACTICE; PRE-
                                  18               SCRIPTION.—With                    respect to the emergency use of a
                                  19               product for which an authorization under this sec-
                                  20               tion is issued (whether an unapproved product or an
                                  21               unapproved use of an approved product), the Sec-
                                  22               retary may waive or limit, to the extent appropriate
                                  23               given the applicable circumstances described in sub-
                                  24               section (b)(1)—





                                              •S 242 IS

                                                                                         56
                                    1                                 ‘‘(A) requirements regarding current good
                                    2                        manufacturing practice otherwise applicable to
                                    3                        the manufacture, processing, packing, or hold-
                                    4                        ing of products subject to regulation under this
                                    5                        Act, including such requirements established
                                    6                        under section 501 or 520(f)(1), and including
                                    7                        relevant conditions prescribed with respect to
                                    8                        the       product           by        an        order           under   section
                                    9                        520(f)(2);
                                  10                                  ‘‘(B) requirements established under sec-
                                  11                         tion 503(b); and
                                  12                                  ‘‘(C) requirements established under sec-
                                  13                         tion 520(e).’’;
                                  14                         (6) in subsection (g)—
                                  15                                  (A) in the subsection heading, by inserting
                                  16                         ‘‘REVIEW         AND’’          before ‘‘REVOCATION’’;
                                  17                                  (B) in paragraph (1), by inserting after
                                  18                         the period at the end the following: ‘‘As part of
                                  19                         such review, the Secretary shall regularly review
                                  20                         the progress made with respect to the approval,
                                  21                         licensure, or clearance of—
                                  22                                  ‘‘(A) an unapproved product for which an
                                  23                         authorization was issued under this section; or





                                              •S 242 IS

                                                                                         57
                                    1                                 ‘‘(B) an unapproved use of an approved
                                    2                        product for which an authorization was issued
                                    3                        under this section.’’; and
                                    4                                 (C) by amending paragraph (2) to read as
                                    5                        follows:
                                    6                        ‘‘(2) REVISION                  AND REVOCATION.—The                   Sec-
                                    7              retary may revise or revoke an authorization under
                                    8              this section if—
                                    9                                 ‘‘(A) the circumstances described under
                                  10                         subsection (b)(1) no longer exist;
                                  11                                  ‘‘(B) the criteria under subsection (c) for
                                  12                         issuance of such authorization are no longer
                                  13                         met; or
                                  14                                  ‘‘(C) other circumstances make such revi-
                                  15                         sion or revocation appropriate to protect the
                                  16                         public health or safety.’’;
                                  17                         (7) in subsection (h)(1), by adding after the pe-
                                  18               riod at the end the following: ‘‘The Secretary shall
                                  19               make any revisions to an authorization under this
                                  20               section available on the Internet Web site of the
                                  21               Food and Drug Administration.’’;
                                  22                         (8) by adding at the end of subsection (j) the
                                  23               following:
                                  24                         ‘‘(4) Nothing in this section shall be construed




                                  25               as authorizing a delay in the review or other consid-
                                              •S 242 IS

                                                                                         58
                                    1              eration by the Secretary of any application or sub-
                                    2              mission pending before the Food and Drug Adminis-
                                    3              tration for a product for which an authorization
                                    4              under this section is issued.’’; and
                                    5                        (9) by adding at the end the following:
                                    6              ‘‘(m) CATEGORIZATION                         OF       LABORATORY TESTS AS-
                                    7     SOCIATED              WITH DEVICES SUBJECT                                  TO       AUTHORIZA-
                                    8     TION.—

                                    9                        ‘‘(1) IN      GENERAL.—In                   issuing an authorization
                                  10               under this section with respect to a device, the Sec-
                                  11               retary may, subject to the provisions of this section,
                                  12               determine that a laboratory examination or proce-
                                  13               dure associated with such device shall be deemed, for
                                  14               purposes of section 353 of the Public Health Service
                                  15               Act, to be in a particular category of examinations
                                  16               and procedures (including the category described by
                                  17               subsection (d)(3) of such section) if, based on the to-
                                  18               tality of scientific evidence available to the Sec-
                                  19               retary—
                                  20                                  ‘‘(A) such categorization would be bene-
                                  21                         ficial to protecting the public health; and
                                  22                                  ‘‘(B) the known and potential benefits of
                                  23                         such categorization under the circumstances of
                                  24                         the authorization outweigh the known and po-




                                  25                         tential risks of the categorization.
                                              •S 242 IS

                                                                                         59
                                    1                        ‘‘(2) CONDITIONS                     OF DETERMINATION.—The
                                    2              Secretary may establish appropriate conditions on
                                    3              the performance of the examination or procedure
                                    4              pursuant to such determination.
                                    5                        ‘‘(3) EFFECTIVE                     PERIOD.—A                   determination
                                    6              under this subsection shall be effective for purposes
                                    7              of section 353 of the Public Health Service Act not-
                                    8              withstanding any other provision of that section dur-
                                    9              ing the effective period of the relevant declaration
                                  10               under subsection (b).’’.
                                  11               (b) EMERGENCY USE                            OF       MEDICAL PRODUCTS.—
                                  12 Subchapter E of chapter V of the Federal Food, Drug,
                                  13 and Cosmetic Act (21 U.S.C. 360bbb et seq.) is amended
                                  14 by inserting after section 564 the following:
                                  15      ‘‘SEC. 564A. EMERGENCY USE OF MEDICAL PRODUCTS.

                                  16               ‘‘(a) DEFINITIONS.—In this section:
                                  17                         ‘‘(1) ELIGIBLE                  PRODUCT.—The                    term ‘eligible
                                  18               product’ means a product that—
                                  19                                  ‘‘(A) is approved or cleared under this
                                  20                         chapter or licensed under section 351 of the
                                  21                         Public Health Service Act;
                                  22                                  ‘‘(B)(i) is intended for use to prevent, di-
                                  23                         agnose, or treat a disease or condition involving
                                  24                         a biological, chemical, radiological, or nuclear




                                  25                         agent or agents; or
                                              •S 242 IS

                                                                                         60
                                    1                                 ‘‘(ii) is intended for use to prevent, diag-
                                    2                        nose, or treat a serious or life-threatening dis-
                                    3                        ease or condition caused by a product described
                                    4                        in clause (i); and
                                    5                                 ‘‘(C) is intended for use during the cir-
                                    6                        cumstances under which—
                                    7                                        ‘‘(i) a determination described in sub-
                                    8                                 paragraph (A), (B), or (C) of section
                                    9                                 564(b)(1) has been made by the Secretary
                                  10                                  of Homeland Security, the Secretary of
                                  11                                  Defense, or the Secretary, respectively; or
                                  12                                         ‘‘(ii) the identification of a material
                                  13                                  threat described in subparagraph (D) of
                                  14                                  section 564(b)(1) has been made pursuant
                                  15                                  to section 319F–2 of the Public Health
                                  16                                  Service Act.
                                  17                         ‘‘(2) PRODUCT.—The term ‘product’ means a
                                  18               drug, device, or biological product.
                                  19               ‘‘(b) EXPIRATION DATING.—
                                  20                         ‘‘(1) IN       GENERAL.—The                     Secretary may extend
                                  21               the expiration date and authorize the introduction or
                                  22               delivery for introduction into interstate commerce of
                                  23               an eligible product after the expiration date provided
                                  24               by the manufacturer if—





                                              •S 242 IS

                                                                                         61
                                    1                                 ‘‘(A) the expiration date extension is in-
                                    2                        tended to support the United States ability to
                                    3                        protect—
                                    4                                        ‘‘(i) the public health; or
                                    5                                        ‘‘(ii) military preparedness and effec-
                                    6                                 tiveness; and
                                    7                                 ‘‘(B) the expiration date extension is sup-
                                    8                        ported by an appropriate scientific evaluation
                                    9                        that is conducted or accepted by the Secretary.
                                  10                         ‘‘(2) REQUIREMENTS                          AND CONDITIONS.—Any
                                  11               extension of an expiration date under paragraph (1)
                                  12               shall, as part of the extension, identify—
                                  13                                  ‘‘(A) each specific lot, batch, or other unit
                                  14                         of the product for which extended expiration is
                                  15                         authorized;
                                  16                                  ‘‘(B) the duration of the extension; and
                                  17                                  ‘‘(C) any other requirements or conditions
                                  18                         as the Secretary may deem appropriate for the
                                  19                         protection of the public health, which may in-
                                  20                         clude requirements for, or conditions on, prod-
                                  21                         uct sampling, storage, packaging or repack-
                                  22                         aging, transport, labeling, notice to product re-
                                  23                         cipients, recordkeeping, periodic testing or re-
                                  24                         testing, or product disposition.





                                              •S 242 IS

                                                                                         62
                                    1                        ‘‘(3) EFFECT.—Notwithstanding any other pro-
                                    2              vision of this Act or the Public Health Service Act,
                                    3              an eligible product shall not be considered an unap-
                                    4              proved product (as defined in section 564(a)(2)(A))
                                    5              and shall not be deemed adulterated or misbranded
                                    6              under this Act because, with respect to such prod-
                                    7              uct, the Secretary has, under paragraph (1), ex-
                                    8              tended the expiration date and authorized the intro-
                                    9              duction or delivery for introduction into interstate
                                  10               commerce of such product after the expiration date
                                  11               provided by the manufacturer.
                                  12                         ‘‘(4) EXPIRATION                  DATE.—For               purposes of this
                                  13               subsection, the term ‘expiration date’ means the
                                  14               date established through appropriate stability testing
                                  15               required by the regulations issued by the Secretary
                                  16               to ensure that the product meets applicable stand-
                                  17               ards of identity, strength, quality, and purity at the
                                  18               time of use.
                                  19               ‘‘(c) CURRENT GOOD MANUFACTURING PRACTICE.—
                                  20                         ‘‘(1) IN       GENERAL.—The                      Secretary may, when
                                  21               the circumstances of a domestic, military, or public
                                  22               health emergency or material threat described in
                                  23               subsection (a)(1)(C) so warrant, authorize, with re-
                                  24               spect to an eligible product, deviations from current




                                  25               good manufacturing practice requirements otherwise
                                              •S 242 IS

                                                                                         63
                                    1              applicable to the manufacture, processing, packing,
                                    2              or holding of products subject to regulation under
                                    3              this Act, including requirements under section 501
                                    4              or 520(f)(1) or applicable conditions prescribed with
                                    5              respect to the eligible product by an order under sec-
                                    6              tion 520(f)(2).
                                    7                        ‘‘(2) EFFECT.—Notwithstanding any other pro-
                                    8              vision of this Act or the Public Health Service Act,
                                    9              an eligible product shall not be considered an unap-
                                  10               proved product (as defined in section 564(a)(2)(A))
                                  11               and shall not be deemed adulterated or misbranded
                                  12               under this Act because, with respect to such prod-
                                  13               uct, the Secretary has authorized deviations from
                                  14               current good manufacturing practices under para-
                                  15               graph (1).
                                  16               ‘‘(d) EMERGENCY DISPENSING.—The requirements
                                  17 of sections 503(b) and 520(e) shall not apply to an eligible
                                  18 product, and the product shall not be considered an unap-
                                  19 proved product (as defined in section 564(a)(2)(A)) and
                                  20 shall not be deemed adulterated or misbranded under this
                                  21 Act because it is dispensed without an individual prescrip-
                                  22 tion, if—
                                  23                         ‘‘(1) the product is dispensed during the cir-
                                  24               cumstances described in subsection (a)(1)(C); and





                                              •S 242 IS

                                                                                         64
                                    1                        ‘‘(2) such dispensing without an individual pre-
                                    2              scription occurs—
                                    3                                 ‘‘(A) as permitted under the law of the
                                    4                        State in which the product is dispensed; or
                                    5                                 ‘‘(B) in accordance with an order issued by
                                    6                        the Secretary, for the purposes and duration of
                                    7                        the       circumstances                described               in     subsection
                                    8                        (a)(1)(C).
                                    9              ‘‘(e) EMERGENCY USE INSTRUCTIONS.—
                                  10                         ‘‘(1) IN             GENERAL.—The                      Secretary, acting
                                  11               through an appropriate official within the Depart-
                                  12               ment of Health and Human Services, may create
                                  13               and issue emergency use instructions to inform
                                  14               health care providers or individuals to whom an eli-
                                  15               gible product is to be administered concerning such
                                  16               product’s approved, licensed, or cleared conditions of
                                  17               use.
                                  18                         ‘‘(2) EFFECT.—Notwithstanding any other pro-
                                  19               visions of this Act or the Public Health Service Act,
                                  20               a product shall not be considered an unapproved
                                  21               product and shall not be deemed adulterated or mis-
                                  22               branded under this Act because of the issuance of
                                  23               emergency use instructions under paragraph (1)
                                  24               with respect to such product or the introduction or





                                              •S 242 IS

                                                                                         65
                                    1              delivery for introduction of such product into inter-
                                    2              state commerce accompanied by such instructions—
                                    3                                 ‘‘(A) during an emergency response to an
                                    4                        actual emergency that is the basis for a deter-
                                    5                        mination described in subsection (a)(1)(C)(i); or
                                    6                                 ‘‘(B) by a government entity (including a
                                    7                        Federal, State, local, or tribal government enti-
                                    8                        ty), or a person acting on behalf of such a gov-
                                    9                        ernment entity, in preparation for an emer-
                                  10                         gency response.’’.
                                  11               (c) RISK EVALUATION                           AND        MITIGATION STRATE-
                                  12      GIES.—Section                 505–1 of the Federal Food, Drug, and
                                  13 Cosmetic Act (21 U.S.C. 355–1), is amended—
                                  14                         (1) in subsection (f), by striking paragraph (7);
                                  15               and
                                  16                         (2) by adding at the end the following:
                                  17               ‘‘(k) WAIVER              IN    PUBLIC HEALTH EMERGENCIES.—
                                  18 The Secretary may waive any requirement of this section
                                  19 with respect to a qualified countermeasure (as defined in
                                  20 section 319F–1(a)(2) of the Public Health Service Act)
                                  21 to which a requirement under this section has been ap-
                                  22 plied, if the Secretary determines that such waiver is re-
                                  23 quired to mitigate the effects of, or reduce the severity
                                  24 of, the circumstances under which—





                                              •S 242 IS

                                                                                         66
                                    1                        ‘‘(1) a determination described in subparagraph
                                    2              (A), (B), or (C) of section 564(b)(1) has been made
                                    3              by the Secretary of Homeland Security, the Sec-
                                    4              retary of Defense, or the Secretary, respectively; or
                                    5                        ‘‘(2) the identification of a material threat de-
                                    6              scribed in subparagraph (D) of section 564(b)(1)
                                    7              has been made pursuant to section 319F–2 of the
                                    8              Public Health Service Act.’’.
                                    9              (d) PRODUCTS HELD                          FOR        EMERGENCY USE.—The
                                  10 Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301
                                  11 et seq.) is amended by inserting after section 564A, as
                                  12 added by subsection (b), the following:
                                  13      ‘‘SEC. 564B. PRODUCTS HELD FOR EMERGENCY USE.

                                  14               ‘‘It is not a violation of any section of this Act or
                                  15 of the Public Health Service Act for a government entity
                                  16 (including a Federal, State, local, or tribal government en-
                                  17 tity), or a person acting on behalf of such a government
                                  18 entity, to introduce into interstate commerce a product (as
                                  19 defined in section 564(a)(4)) intended for emergency use,
                                  20 if that product—
                                  21                         ‘‘(1) is intended to be held and not used; and
                                  22                         ‘‘(2) is held and not used, unless and until that
                                  23               product—





                                              •S 242 IS

                                                                                         67
                                    1                                 ‘‘(A) is approved, cleared, or licensed
                                    2                        under section 505, 510(k), or 515 of this Act
                                    3                        or section 351 of the Public Health Service Act;
                                    4                                 ‘‘(B) is authorized for investigational use
                                    5                        under section 505 or 520 of this Act or section
                                    6                        351 of the Public Health Service Act; or
                                    7                                 ‘‘(C) is authorized for use under section
                                    8                        564.’’.
                                    9     SEC. 303. DEFINITIONS.
                                  10               Section 565 of the Federal Food, Drug, and Cosmetic
                                  11 Act (21 U.S.C. 360bbb–4) is amended by striking ‘‘The
                                  12 Secretary, in consultation’’ and inserting the following:
                                  13               ‘‘(a) DEFINITIONS.—In this section—
                                  14                         ‘‘(1) the term ‘countermeasure’ means a quali-
                                  15               fied countermeasure, a security countermeasure, and
                                  16               a qualified pandemic or epidemic product;
                                  17                         ‘‘(2) the term ‘qualified countermeasure’ has
                                  18               the meaning given such term in section 319F–1 of
                                  19               the Public Health Service Act;
                                  20                         ‘‘(3) the term ‘security countermeasure’ has the
                                  21               meaning given such term in section 319F–2 of such
                                  22               Act; and
                                  23                         ‘‘(4) the term ‘qualified pandemic or epidemic
                                  24               product’ means a product that meets the definition





                                              •S 242 IS

                                                                                         68
                                    1              given such term in section 319F–3 of the Public
                                    2              Health Service Act and—
                                    3                                 ‘‘(A) that has been identified by the De-
                                    4                        partment of Health and Human Services or the
                                    5                        Department of Defense as receiving funding di-
                                    6                        rectly related to addressing chemical, biological,
                                    7                        radiological, or nuclear threats, including pan-
                                    8                        demic influenza; or
                                    9                                 ‘‘(B) is included under this paragraph pur-
                                  10                         suant to a determination by the Secretary.
                                  11               ‘‘(b) GENERAL DUTIES.—The Secretary, in consulta-
                                  12 tion’’.
                                  13      SEC. 304. ENHANCING MEDICAL COUNTERMEASURE AC-
                                  14                              TIVITIES.
                                  15               Section 565 of the Federal Food, Drug, and Cosmetic
                                  16 Act (21 U.S.C. 360bbb–4), as amended by section 303,
                                  17 is further amended—
                                  18                         (1) in the section heading, by striking ‘‘TECH-
                                  19               NICAL ASSISTANCE’’                            and inserting ‘‘COUNTER-
                                  20               MEASURE DEVELOPMENT, REVIEW, AND TECH-
                                  21               NICAL ASSISTANCE’’;
                                  22                         (2) in subsection (b), by striking the subsection
                                  23               enumerator and all that follows through ‘‘shall es-
                                  24               tablish’’ and inserting the following:





                                              •S 242 IS

                                                                                         69
                                    1              ‘‘(b) GENERAL DUTIES.—In order to accelerate the
                                    2 development, stockpiling, approval, licensure, and clear-
                                    3 ance of qualified countermeasures, security counter-
                                    4 measures, and qualified pandemic or epidemic products,
                                    5 the Secretary, in consultation with the Assistant Secretary
                                    6 for Preparedness and Response, shall—
                                    7                        ‘‘(1) ensure the appropriate involvement of
                                    8              Food and Drug Administration personnel in inter-
                                    9              agency activities related to countermeasure advanced
                                  10               research and development, consistent with sections
                                  11               319F, 319F–1, 319F–2, 319F–3, 319L, and 2811
                                  12               of the Public Health Service Act;
                                  13                         ‘‘(2) ensure the appropriate involvement and
                                  14               consultation of Food and Drug Administration per-
                                  15               sonnel in any flexible manufacturing activities car-
                                  16               ried out under section 319L of the Public Health
                                  17               Service Act, including with respect to meeting regu-
                                  18               latory requirements set forth in this Act;
                                  19                         ‘‘(3) promote countermeasure expertise within
                                  20               the Food and Drug Administration by—
                                  21                                  ‘‘(A) ensuring that Food and Drug Admin-
                                  22                         istration personnel involved in reviewing coun-
                                  23                         termeasures for approval, licensure, or clear-
                                  24                         ance are informed by the Assistant Secretary




                                  25                         for Preparedness and Response on the material
                                              •S 242 IS

                                                                                         70
                                    1                        threat assessment conducted under section
                                    2                        319F–2 of the Public Health Service Act for
                                    3                        the agent or agents for which the counter-
                                    4                        measure under review is intended;
                                    5                                 ‘‘(B) training Food and Drug Administra-
                                    6                        tion personnel regarding review of counter-
                                    7                        measures for approval, licensure, or clearance;
                                    8                                 ‘‘(C) holding public meetings at least twice
                                    9                        annually to encourage the exchange of scientific
                                  10                         ideas; and
                                  11                                  ‘‘(D) establishing protocols to ensure that
                                  12                         countermeasure reviewers have sufficient train-
                                  13                         ing or experience with countermeasures;
                                  14                         ‘‘(4) maintain teams, composed of Food and
                                  15               Drug Administration personnel with expertise on
                                  16               countermeasures,                      including                specific         counter-
                                  17               measures, populations with special clinical needs (in-
                                  18               cluding children and pregnant women that may use
                                  19               countermeasures, as applicable and appropriate),
                                  20               classes or groups of countermeasures, or other coun-
                                  21               termeasure-related technologies and capabilities, that
                                  22               shall—
                                  23                                  ‘‘(A) consult with countermeasure experts,
                                  24                         including countermeasure sponsors and appli-




                                  25                         cants, to identify and help resolve scientific
                                              •S 242 IS

                                                                                         71
                                    1                        issues related to the approval, licensure, or
                                    2                        clearance of countermeasures, through work-
                                    3                        shops or public meetings; and
                                    4                                 ‘‘(B) improve and advance the science re-
                                    5                        lating to the development of new tools, stand-
                                    6                        ards, and approaches to assessing and evalu-
                                    7                        ating countermeasures—
                                    8                                        ‘‘(i) in order to inform the process for
                                    9                                 countermeasure approval, clearance, and li-
                                  10                                  censure; and
                                  11                                         ‘‘(ii) with respect to the development
                                  12                                  of countermeasures for populations with
                                  13                                  special clinical needs, including children
                                  14                                  and pregnant women, in order to meet the
                                  15                                  needs of such populations, as necessary
                                  16                                  and appropriate; and
                                  17                         ‘‘(5) establish’’; and
                                  18                         (3) by adding at the end the following:
                                  19               ‘‘(c) FINAL GUIDANCE                         ON       DEVELOPMENT               OF   ANI-
                                  20      MAL      MODELS.—
                                  21                         ‘‘(1) IN      GENERAL.—Not                     later than 1 year after
                                  22               the date of the enactment of the Pandemic and All-
                                  23               Hazards Preparedness Reauthorization Act of 2013,
                                  24               the Secretary shall provide final guidance to indus-




                                  25               try regarding the development of animal models to
                                              •S 242 IS

                                                                                         72
                                    1              support approval, clearance, or licensure of counter-
                                    2              measures referred to in subsection (a) when human
                                    3              efficacy studies are not ethical or feasible.
                                    4                        ‘‘(2) AUTHORITY                  TO EXTEND DEADLINE.—The
                                    5              Secretary may extend the deadline for providing
                                    6              final guidance under paragraph (1) by not more
                                    7              than 6 months upon submission by the Secretary of
                                    8              a report on the status of such guidance to the Com-
                                    9              mittee on Energy and Commerce of the House of
                                  10               Representatives and the Committee on Health, Edu-
                                  11               cation, Labor, and Pensions of the Senate.
                                  12               ‘‘(d) DEVELOPMENT                         AND     ANIMAL MODELING PRO-
                                  13      CEDURES.—

                                  14                         ‘‘(1) AVAILABILITY                   OF ANIMAL MODEL MEET-
                                  15               INGS.—To              facilitate the timely development of ani-
                                  16               mal models and support the development, stock-
                                  17               piling, licensure, approval, and clearance of counter-
                                  18               measures, the Secretary shall, not later than 180
                                  19               days after the enactment of this subsection, establish
                                  20               a procedure by which a sponsor or applicant that is
                                  21               developing a countermeasure for which human effi-
                                  22               cacy studies are not ethical or practicable, and that
                                  23               has an approved investigational new drug application
                                  24               or investigational device exemption, may request and




                                  25               receive—
                                              •S 242 IS

                                                                                         73
                                    1                                 ‘‘(A) a meeting to discuss proposed animal
                                    2                        model development activities; and
                                    3                                 ‘‘(B) a meeting prior to initiating pivotal
                                    4                        animal studies.
                                    5                        ‘‘(2) PEDIATRIC                 MODELS.—To                facilitate the de-
                                    6              velopment and selection of animal models that could
                                    7              translate to pediatric studies, any meeting conducted
                                    8              under paragraph (1) shall include discussion of ani-
                                    9              mal models for pediatric populations, as appropriate.
                                  10               ‘‘(e)        REVIEW             AND          APPROVAL                    OF     COUNTER-
                                  11      MEASURES.—

                                  12                         ‘‘(1) MATERIAL                  THREAT.—When                    evaluating an
                                  13               application or submission for approval, licensure, or
                                  14               clearance of a countermeasure, the Secretary shall
                                  15               take into account the material threat posed by the
                                  16               chemical, biological, radiological, or nuclear agent or
                                  17               agents identified under section 319F–2 of the Public
                                  18               Health Service Act for which the countermeasure
                                  19               under review is intended.
                                  20                         ‘‘(2) REVIEW                EXPERTISE.—When                           practicable
                                  21               and appropriate, teams of Food and Drug Adminis-
                                  22               tration personnel reviewing applications or submis-
                                  23               sions described under paragraph (1) shall include a
                                  24               reviewer with sufficient training or experience with





                                              •S 242 IS

                                                                                         74
                                    1              countermeasures pursuant to the protocols estab-
                                    2              lished under subsection (b)(3)(D).’’.
                                    3     SEC. 305. REGULATORY MANAGEMENT PLANS.
                                    4              Section 565 of the Federal Food, Drug, and Cosmetic
                                    5 Act (21 U.S.C. 360bbb–4), as amended by section 304,
                                    6 is further amended by adding at the end the following:
                                    7              ‘‘(f) REGULATORY MANAGEMENT PLAN.—
                                    8                        ‘‘(1) DEFINITION.—In this subsection, the term
                                    9              ‘eligible countermeasure’ means—
                                  10                                  ‘‘(A) a security countermeasure with re-
                                  11                         spect to which the Secretary has entered into a
                                  12                         procurement contract under section 319F–2(c)
                                  13                         of the Public Health Service Act; or
                                  14                                  ‘‘(B) a countermeasure with respect to
                                  15                         which the Biomedical Advanced Research and
                                  16                         Development Authority has provided funding
                                  17                         under section 319L of the Public Health Serv-
                                  18                         ice Act for advanced research and development.
                                  19                         ‘‘(2) REGULATORY                     MANAGEMENT PLAN PROC-
                                  20               ESS.—The              Secretary, in consultation with the As-
                                  21               sistant Secretary for Preparedness and Response
                                  22               and the Director of the Biomedical Advanced Re-
                                  23               search and Development Authority, shall establish a
                                  24               formal process for obtaining scientific feedback and




                                  25               interactions regarding the development and regu-
                                              •S 242 IS

                                                                                         75
                                    1              latory review of eligible countermeasures by facili-
                                    2              tating the development of written regulatory man-
                                    3              agement plans in accordance with this subsection.
                                    4                        ‘‘(3) SUBMISSION                  OF REQUEST AND PROPOSED
                                    5              PLAN BY SPONSOR OR APPLICANT.—
                                    6                                 ‘‘(A) IN         GENERAL.—A                   sponsor or appli-
                                    7                        cant of an eligible countermeasure may initiate
                                    8                        the process described under paragraph (2) upon
                                    9                        submission of a written request to the Sec-
                                  10                         retary. Such request shall include a proposed
                                  11                         regulatory management plan.
                                  12                                  ‘‘(B) TIMING              OF SUBMISSION.—A                   sponsor
                                  13                         or applicant may submit a written request
                                  14                         under subparagraph (A) after the eligible coun-
                                  15                         termeasure has an investigational new drug or
                                  16                         investigational device exemption in effect.
                                  17                                  ‘‘(C)       RESPONSE                BY        SECRETARY.—The
                                  18                         Secretary shall direct the Food and Drug Ad-
                                  19                         ministration, upon submission of a written re-
                                  20                         quest by a sponsor or applicant under subpara-
                                  21                         graph (A), to work with the sponsor or appli-
                                  22                         cant to agree on a regulatory management plan
                                  23                         within a reasonable time not to exceed 90 days.
                                  24                         If the Secretary determines that no plan can be




                                  25                         agreed upon, the Secretary shall provide to the
                                              •S 242 IS

                                                                                         76
                                    1                        sponsor or applicant, in writing, the scientific
                                    2                        or regulatory rationale why such agreement
                                    3                        cannot be reached.
                                    4                        ‘‘(4) PLAN.—The content of a regulatory man-
                                    5              agement plan agreed to by the Secretary and a spon-
                                    6              sor or applicant shall include—
                                    7                                 ‘‘(A) an agreement between the Secretary
                                    8                        and the sponsor or applicant regarding develop-
                                    9                        mental milestones that will trigger responses by
                                  10                         the Secretary as described in subparagraph (B);
                                  11                                  ‘‘(B) performance targets and goals for
                                  12                         timely and appropriate responses by the Sec-
                                  13                         retary to the triggers described under subpara-
                                  14                         graph (A), including meetings between the Sec-
                                  15                         retary and the sponsor or applicant, written
                                  16                         feedback, decisions by the Secretary, and other
                                  17                         activities carried out as part of the development
                                  18                         and review process; and
                                  19                                  ‘‘(C) an agreement on how the plan shall
                                  20                         be modified, if needed.
                                  21                         ‘‘(5) MILESTONES                      AND        PERFORMANCE          TAR-
                                  22               GETS.—The                developmental milestones described in
                                  23               paragraph (4)(A) and the performance targets and
                                  24               goals described in paragraph (4)(B) shall include—





                                              •S 242 IS

                                                                                         77
                                    1                                 ‘‘(A) feedback from the Secretary regard-
                                    2                        ing the data required to support the approval,
                                    3                        clearance, or licensure of the eligible counter-
                                    4                        measure involved;
                                    5                                 ‘‘(B) feedback from the Secretary regard-
                                    6                        ing the data necessary to inform any authoriza-
                                    7                        tion under section 564;
                                    8                                 ‘‘(C) feedback from the Secretary regard-
                                    9                        ing the data necessary to support the posi-
                                  10                         tioning and delivery of the eligible counter-
                                  11                         measure, including to the Strategic National
                                  12                         Stockpile;
                                  13                                  ‘‘(D) feedback from the Secretary regard-
                                  14                         ing the data necessary to support the submis-
                                  15                         sion of protocols for review under section
                                  16                         505(b)(5)(B);
                                  17                                  ‘‘(E) feedback from the Secretary regard-
                                  18                         ing any gaps in scientific knowledge that will
                                  19                         need resolution prior to approval, licensure, or
                                  20                         clearance of the eligible countermeasure and
                                  21                         plans for conducting the necessary scientific re-
                                  22                         search;
                                  23                                  ‘‘(F) identification of the population for
                                  24                         which the countermeasure sponsor or applicant




                                  25                         seeks approval, licensure, or clearance and the
                                              •S 242 IS

                                                                                         78
                                    1                        population for which desired labeling would not
                                    2                        be appropriate, if known; and
                                    3                                 ‘‘(G) as necessary and appropriate, and to
                                    4                        the extent practicable, a plan for demonstrating
                                    5                        safety and effectiveness in pediatric popu-
                                    6                        lations, and for developing pediatric dosing, for-
                                    7                        mulation, and administration with respect to
                                    8                        the eligible countermeasure, provided that such
                                    9                        plan would not delay authorization under sec-
                                  10                         tion 564, approval, licensure, or clearance for
                                  11                         adults.
                                  12                         ‘‘(6) PRIORITIZATION.—
                                  13                                  ‘‘(A) PLANS                FOR         SECURITY              COUNTER-
                                  14                         MEASURES.—The                    Secretary shall establish reg-
                                  15                         ulatory management plans for all security coun-
                                  16                         termeasures for which a request is submitted
                                  17                         under paragraph (3)(A).
                                  18                                  ‘‘(B) PLANS             FOR OTHER ELIGIBLE COUN-
                                  19                         TERMEASURES.—The                        Secretary shall determine
                                  20                         whether resources are available to establish reg-
                                  21                         ulatory management plans for eligible counter-
                                  22                         measures             that        are        not        security        counter-
                                  23                         measures. If resources are available to establish
                                  24                         regulatory management plans for eligible coun-




                                  25                         termeasures that are not security counter-
                                              •S 242 IS

                                                                                         79
                                    1                        measures, and if resources are not available to
                                    2                        establish regulatory management plans for all
                                    3                        eligible countermeasures for which requests
                                    4                        have been submitted, the Director of the Bio-
                                    5                        medical Advanced Research and Development
                                    6                        Authority, in consultation with the Commis-
                                    7                        sioner, shall prioritize which eligible counter-
                                    8                        measures may receive regulatory management
                                    9                        plans.’’.
                                  10      SEC. 306. REPORT.
                                  11               Section 565 of the Federal Food, Drug, and Cosmetic
                                  12 Act (21 U.S.C. 360bbb–4), as amended by section 305,
                                  13 is further amended by adding at the end the following:
                                  14               ‘‘(g) ANNUAL REPORT.—Not later than 180 days
                                  15 after the date of enactment of this subsection, and annu-
                                  16 ally thereafter, the Secretary shall make publicly available
                                  17 on the Web site of the Food and Drug Administration a
                                  18 report that details the countermeasure development and
                                  19 review activities of the Food and Drug Administration, in-
                                  20 cluding—
                                  21                         ‘‘(1) with respect to the development of new
                                  22               tools, standards, and approaches to assess and
                                  23               evaluate countermeasures—





                                              •S 242 IS

                                                                                         80
                                    1                                 ‘‘(A) the identification of the priorities of
                                    2                        the Food and Drug Administration and the
                                    3                        progress made on such priorities; and
                                    4                                 ‘‘(B) the identification of scientific gaps
                                    5                        that impede the development, approval, licen-
                                    6                        sure, or clearance of countermeasures for popu-
                                    7                        lations with special clinical needs, including
                                    8                        children and pregnant women, and the progress
                                    9                        made on resolving these challenges;
                                  10                         ‘‘(2) with respect to countermeasures for which
                                  11               a regulatory management plan has been agreed upon
                                  12               under subsection (f), the extent to which the per-
                                  13               formance targets and goals set forth in subsection
                                  14               (f)(4)(B) and the regulatory management plan have
                                  15               been met, including, for each such countermeasure—
                                  16                                  ‘‘(A) whether the regulatory management
                                  17                         plan was completed within the required time-
                                  18                         frame, and the length of time taken to complete
                                  19                         such plan;
                                  20                                  ‘‘(B) whether the Secretary adhered to the
                                  21                         timely and appropriate response times set forth
                                  22                         in such plan; and
                                  23                                  ‘‘(C) explanations for any failure to meet
                                  24                         such performance targets and goals;





                                              •S 242 IS

                                                                                         81
                                    1                        ‘‘(3) the number of regulatory teams estab-
                                    2              lished pursuant to subsection (b)(4), the number of
                                    3              products, classes of products, or technologies as-
                                    4              signed to each such team, and the number of, type
                                    5              of, and any progress made as a result of consulta-
                                    6              tions carried out under subsection (b)(4)(A);
                                    7                        ‘‘(4) an estimate of resources obligated to coun-
                                    8              termeasure development and regulatory assessment,
                                  109              including—       ‘‘(A) Center-specific objectives and accom-
                                  11                         plishments; and
                                  12                                  ‘‘(B) the number of full-time equivalent
                                  13                         employees of the Food and Drug Administra-
                                  14                         tion who directly support the review of counter-
                                  15                         measures;
                                  16                         ‘‘(5) the number of countermeasure applications
                                  17               and submissions submitted, the number of counter-
                                  18               measures approved, licensed, or cleared, the status
                                  19               of remaining submitted applications and submis-
                                  20               sions, and the number of each type of authorization
                                  21               issued pursuant to section 564;
                                  22                         ‘‘(6) the number of written requests for a regu-
                                  23               latory management plan submitted under subsection
                                  24               (f)(3)(A), the number of regulatory management





                                              •S 242 IS

                                                                                         82
                                    1              plans developed, and the number of such plans de-
                                    2              veloped for security countermeasures; and
                                    3                        ‘‘(7) the number, type, and frequency of meet-
                                    4              ings between the Food and Drug Administration
                                    5              and—
                                    6                                 ‘‘(A) sponsors of a countermeasure as de-
                                    7                        fined in subsection (a); or
                                    8                                 ‘‘(B) another agency engaged in develop-
                                    9                        ment or management of portfolios for such
                                  10                         countermeasures, including the Centers for Dis-
                                  11                         ease Control and Prevention, the Biomedical
                                  12                         Advanced Research and Development Authority,
                                  13                         the National Institutes of Health, and the ap-
                                  14                         propriate agencies of the Department of De-
                                  15                         fense.’’.
                                  16      SEC. 307. PEDIATRIC MEDICAL COUNTERMEASURES.

                                  17               (a) PEDIATRIC STUDIES                           OF     DRUGS.—Section 505A
                                  18 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
                                  19 355a) is amended—
                                  20                         (1) in subsection (d), by adding at the end the
                                  21               following:
                                  22                         ‘‘(5) CONSULTATION.—With respect to a drug
                                  23               that is a qualified countermeasure (as defined in sec-
                                  24               tion 319F–1 of the Public Health Service Act), a se-




                                  25               curity countermeasure (as defined in section 319F–
                                              •S 242 IS

                                                                                         83
                                    1              2 of the Public Health Service Act), or a qualified
                                    2              pandemic or epidemic product (as defined in section
                                    3              319F–3 of the Public Health Service Act), the Sec-
                                    4              retary shall solicit input from the Assistant Sec-
                                    5              retary for Preparedness and Response regarding the
                                    6              need for and, from the Director of the Biomedical
                                    7              Advanced Research and Development Authority re-
                                    8              garding the conduct of, pediatric studies under this
                                    9              section.’’; and
                                  10                         (2) in subsection (n)(1), by adding at the end
                                  11               the following:
                                  12                                  ‘‘(C) For a drug that is a qualified coun-
                                  13                         termeasure (as defined in section 319F–1 of the
                                  14                         Public Health Service Act), a security counter-
                                  15                         measure (as defined in section 319F–2 of the
                                  16                         Public Health Service Act), or a qualified pan-
                                  17                         demic or epidemic product (as defined in sec-
                                  18                         tion 319F–3 of such Act), in addition to any
                                  19                         action with respect to such drug under subpara-
                                  20                         graph (A) or (B), the Secretary shall notify the
                                  21                         Assistant Secretary for Preparedness and Re-
                                  22                         sponse and the Director of the Biomedical Ad-
                                  23                         vanced Research and Development Authority of
                                  24                         all pediatric studies in the written request





                                              •S 242 IS

                                                                                         84
                                    1                        issued by the Commissioner of Food and
                                    2                        Drugs.’’.
                                    3              (b)       ADDITION               TO        PRIORITY              LIST           CONSIDER-
                                    4     ATIONS.—Section                   409I of the Public Health Service Act
                                    5 (42 U.S.C. 284m) is amended—
                                    6                        (1) by striking subsection (a)(2) and inserting
                                    7              the following:
                                    8                        ‘‘(2) CONSIDERATION                         OF AVAILABLE INFORMA-
                                    9              TION.—In             developing and prioritizing the list under
                                  10               paragraph (1), the Secretary—
                                  11                                  ‘‘(A) shall consider—
                                  12                                         ‘‘(i) therapeutic gaps in pediatrics
                                  13                                  that may include developmental pharma-
                                  14                                  cology, pharmacogenetic determinants of
                                  15                                  drug response, metabolism of drugs and
                                  16                                  biologics in children, and pediatric clinical
                                  17                                  trials;
                                  18                                         ‘‘(ii) particular pediatric diseases, dis-
                                  19                                  orders or conditions where more complete
                                  20                                  knowledge and testing of therapeutics, in-
                                  21                                  cluding drugs and biologics, may be bene-
                                  22                                  ficial in pediatric populations; and
                                  23                                         ‘‘(iii) the adequacy of necessary infra-
                                  24                                  structure to conduct pediatric pharma-




                                  25                                  cological research, including research net-
                                              •S 242 IS

                                                                                         85
                                    1                                 works and trained pediatric investigators;
                                    2                                 and
                                    3                                 ‘‘(B) may consider the availability of quali-
                                    4                        fied countermeasures (as defined in section
                                    5                        319F–1), security countermeasures (as defined
                                    6                        in section 319F–2), and qualified pandemic or
                                    7                        epidemic products (as defined in section 319F–
                                    8                        3) to address the needs of pediatric populations,
                                    9                        in consultation with the Assistant Secretary for
                                  10                         Preparedness and Response, consistent with the
                                  11                         purposes of this section.’’; and
                                  12                         (2) in subsection (b), by striking ‘‘subsection
                                  13               (a)’’ and inserting ‘‘paragraphs (1) and (2)(A) of
                                  14               subsection (a)’’.
                                  15               (c) ADVICE             AND      RECOMMENDATIONS                          OF THE   PEDI-
                                  16      ATRIC            ADVISORY COMMITTEE REGARDING COUNTER-
                                  17      MEASURES FOR                     PEDIATRIC POPULATIONS.—Subsection
                                  18 (b)(2) of section 14 of the Best Pharmaceuticals for Chil-
                                  19 dren Act (42 U.S.C. 284m note) is amended—
                                  20                         (1) in subparagraph (C), by striking the period
                                  21               and inserting ‘‘; and’’; and
                                  22                         (2) by adding at the end the following:
                                  23                                  ‘‘(D) the development of countermeasures
                                  24                         (as defined in section 565(a) of the Federal





                                              •S 242 IS

                                                                                         86
                                    1                        Food, Drug, and Cosmetic Act) for pediatric
                                    2                        populations.’’.
                                    3     TITLE IV—ACCELERATING MED-
                                    4        ICAL COUNTERMEASURE AD-
                                    5        VANCED RESEARCH AND DE-
                                    6        VELOPMENT
                                    7     SEC. 401. BIOSHIELD.

                                    8              (a) PROCUREMENT                           OF   COUNTERMEASURES.—Sec-
                                    9 tion 319F–2(c) of the Public Health Service Act (42
                                  10 U.S.C. 247d–6b(c)) is amended—
                                  11                         (1) in paragraph (1)(B)(i)(III)(bb), by striking
                                  12               ‘‘eight years’’ and inserting ‘‘10 years’’;
                                  13                         (2) in paragraph (2)(C), by striking ‘‘the des-
                                  14               ignated congressional committees (as defined in
                                  15               paragraph (10))’’ and inserting ‘‘the appropriate
                                  16               committees of Congress’’;
                                  17                         (3) in paragraph (5)(B)(ii), by striking ‘‘eight
                                  18               years’’ and inserting ‘‘10 years’’;
                                  19                         (4) in subparagraph (C) of paragraph (6)—
                                  20                                  (A) in the subparagraph heading, by strik-
                                  21                         ing ‘‘DESIGNATED                      CONGRESSIONAL                    COMMIT-
                                  22                         TEES’’       and inserting ‘‘APPROPRIATE                              CONGRES-
                                  23                         SIONAL COMMITTEES’’;                        and





                                              •S 242 IS

                                                                                         87
                                    1                                 (B) by striking ‘‘the designated congres-
                                    2                        sional committees’’ and inserting ‘‘the appro-
                                    3                        priate congressional committees’’; and
                                    4                        (5) in paragraph (7)(C)—
                                    5                                 (A) in clause (i)(I), by inserting ‘‘including
                                    6                        advanced research and development,’’ after ‘‘as
                                    7                        may reasonably be required,’’;
                                    8                                 (B) in clause (ii)—
                                    9                                        (i) in subclause (III), by striking
                                  10                                  ‘‘eight years’’ and inserting ‘‘10 years’’;
                                  11                                  and
                                  12                                         (ii) by striking subclause (IX) and in-
                                  13                                  serting the following:
                                  14                                                   ‘‘(IX) CONTRACT                       TERMS.—The
                                  15                                         Secretary, in any contract for procure-
                                  16                                         ment under this section—
                                  17                                                            ‘‘(aa) may specify—
                                  18                                                                     ‘‘(AA) the dosing and
                                  19                                                            administration requirements
                                  20                                                            for the countermeasure to be
                                  21                                                            developed and procured;
                                  22                                                                     ‘‘(BB) the amount of
                                  23                                                            funding that will be dedi-
                                  24                                                            cated by the Secretary for




                                  25                                                            advanced research, develop-
                                              •S 242 IS

                                                                                         88
                                    1                                                           ment, and procurement of
                                    2                                                           the countermeasure; and
                                    3                                                                    ‘‘(CC) the specifications
                                    4                                                           the        countermeasure          must
                                    5                                                           meet to qualify for procure-
                                    6                                                           ment under a contract under
                                    7                                                           this section; and
                                    8                                                           ‘‘(bb) shall provide a clear
                                    9                                                  statement of defined Government
                                  10                                                   purpose limited to uses related to
                                  11                                                   a security countermeasure, as de-
                                  12                                                   fined in paragraph (1)(B).’’; and
                                  13                                  (C) by adding at the end the following:
                                  14                                         ‘‘(viii) FLEXIBILITY.—In carrying out
                                  15                                  this section, the Secretary may, consistent
                                  16                                  with the applicable provisions of this sec-
                                  17                                  tion, enter into contracts and other agree-
                                  18                                  ments that are in the best interest of the
                                  19                                  Government in meeting identified security
                                  20                                  countermeasure needs, including with re-
                                  21                                  spect to reimbursement of the cost of ad-
                                  22                                  vanced research and development as a rea-
                                  23                                  sonable, allowable, and allocable direct cost
                                  24                                  of the contract involved.’’.





                                              •S 242 IS

                                    1              (b) REAUTHORIZATION                   89      OF THE           SPECIAL RESERVE
                                    2 FUND.—Section 319F–2 of the Public Health Service Act
                                    3 (42 U.S.C. 247d–6b) is amended—
                                    4                        (1) in subsection (c)—
                                    5                                 (A) by striking ‘‘special reserve fund under
                                    6                        paragraph (10)’’ each place it appears and in-
                                    7                        serting ‘‘special reserve fund as defined in sub-
                                    8                        section (h)’’; and
                                  109                        and      (B) by striking paragraphs (9) and (10);
                                  11                         (2) by adding at the end the following:
                                  12               ‘‘(g) SPECIAL RESERVE FUND.—
                                  13                         ‘‘(1) AUTHORIZATION                     OF APPROPRIATIONS.—In
                                  14               addition to amounts appropriated to the special re-
                                  15               serve fund prior to the date of the enactment of this
                                  16               subsection, there is authorized to be appropriated,
                                  17               for the procurement of security countermeasures
                                  18               under subsection (c) and for carrying out section
                                  19               319L (relating to the Biomedical Advanced Research
                                  20               and Development Authority), $2,800,000,000 for the
                                  21               period of fiscal years 2014 through 2018. Amounts
                                  22               appropriated pursuant to the preceding sentence are
                                  23               authorized to remain available until September 30,
                                  24               2019.
                                              •S 242 IS

                                                                                         90
                                    1                        ‘‘(2) USE            OF SPECIAL RESERVE FUND FOR AD-
                                    2              VANCED RESEARCH AND DEVELOPMENT.—The                                                Sec-
                                    3              retary may utilize not more than 50 percent of the
                                    4              amounts authorized to be appropriated under para-
                                    5              graph (1) to carry out section 319L (related to the
                                    6              Biomedical Advanced Research and Development
                                    7              Authority). Amounts authorized to be appropriated
                                    8              under this subsection to carry out section 319L are
                                    9              in addition to amounts otherwise authorized to be
                                  10               appropriated to carry out such section.
                                  11                         ‘‘(3) RESTRICTIONS                          ON     USE         OF     FUNDS.—
                                  12               Amounts in the special reserve fund shall not be
                                  13               used to pay costs other than payments made by the
                                  14               Secretary to a vendor for advanced development
                                  15               (under section 319L) or for procurement of a secu-
                                  16               rity countermeasure under subsection (c)(7).
                                  17                         ‘‘(4) REPORT.—Not later than 30 days after
                                  18               any date on which the Secretary determines that the
                                  19               amount of funds in the special reserve fund available
                                  20               for procurement is less than $1,500,000,000, the
                                  21               Secretary shall submit to the appropriate committees
                                  22               of Congress a report detailing the amount of such
                                  23               funds available for procurement and the impact such
                                  24               reduction in funding will have—





                                              •S 242 IS

                                                                                         91
                                    1                                 ‘‘(A) in meeting the security counter-
                                    2                        measure needs identified under this section; and
                                    3                                 ‘‘(B) on the annual Public Health Emer-
                                    4                        gency Medical Countermeasures Enterprise and
                                    5                        Strategy Implementation Plan (pursuant to sec-
                                    6                        tion 2811(d)).
                                    7              ‘‘(h) DEFINITIONS.—In this section:
                                    8                        ‘‘(1) The term ‘advanced research and develop-
                                    9              ment’ has the meaning given such term in section
                                  10               319L(a).
                                  11                         ‘‘(2) The term ‘special reserve fund’ means the
                                  12               ‘Biodefense Countermeasures’ appropriations ac-
                                  13               count, any appropriation made available pursuant to
                                  14               section 521(a) of the Homeland Security Act of
                                  15               2002, and any appropriation made available pursu-
                                  16               ant to subsection (g)(1).’’.
                                  17      SEC. 402. BIOMEDICAL ADVANCED RESEARCH AND DEVEL-
                                  18                              OPMENT AUTHORITY.
                                  19               (a) DUTIES.—Section 319L(c)(4) of the Public
                                  20 Health Service Act (42 U.S.C. 247d–7e(c)(4)) is amend-
                                  21 ed—
                                  22                         (1) in subparagraph (B)(iii), by inserting
                                  23               ‘‘(which may include advanced research and develop-
                                  24               ment for purposes of fulfilling requirements under





                                              •S 242 IS

                                                                                         92
                                    1              the Federal Food, Drug, and Cosmetic Act or sec-
                                    2              tion 351 of this Act)’’ after ‘‘development’’; and
                                    3                        (2) in subparagraph (D)(iii), by striking ‘‘and
                                    4              vaccine manufacturing technologies’’ and inserting
                                    5              ‘‘vaccine-manufacturing technologies, dose-sparing
                                    6              technologies, efficacy-increasing technologies, and
                                    7              platform technologies’’.
                                    8              (b)                TRANSACTION                        AUTHORITIES.—Section
                                    9 319L(c)(5) of the Public Health Service Act (42 U.S.C.
                                  10 247d–7e(c)(5)) is amended by adding at the end the fol-
                                  11 lowing:
                                  12                                  ‘‘(G) GOVERNMENT                       PURPOSE.—In           award-
                                  13                         ing contracts, grants, and cooperative agree-
                                  14                         ments under this section, the Secretary shall
                                  15                         provide a clear statement of defined Govern-
                                  16                         ment purpose related to activities included in
                                  17                         subsection (a)(6)(B) for a qualified counter-
                                  18                         measure or qualified pandemic or epidemic
                                  19                         product.’’.
                                  20               (c) FUND.—Paragraph (2) of section 319L(d) of the
                                  21 Public Health Service Act (42 U.S.C. 247d–7e(d)(2)) is
                                  22 amended to read as follows:
                                  23                         ‘‘(2) FUNDING.—To carry out the purposes of
                                  24               this section, there is authorized to be appropriated




                                  25               to the Fund $415,000,000 for each of fiscal years
                                              •S 242 IS

                                                                                         93
                                    1              2014 through 2018, such amounts to remain avail-
                                    2              able until expended.’’.
                                    3              (d) CONTINUED INAPPLICABILITY                                    OF      CERTAIN PRO-
                                    4     VISIONS.—Section                    319L(e)(1)(C) of the Public Health
                                    5 Service Act (42 U.S.C. 247d–7e(e)(1)(C)) is amended by
                                    6 striking ‘‘7 years’’ and inserting ‘‘12 years’’.
                                    7              (e) EXTENSION                    OF       LIMITED ANTITRUST EXEMP-
                                    8     TION.—

                                    9                        (1) IN       GENERAL.—Section                       405(b) of the Pan-
                                  10               demic and All-Hazards Preparedness Act (42 U.S.C.
                                  11               247d–6a note) is amended by striking ‘‘6-year’’ and
                                  12               inserting ‘‘12-year’’.
                                  13                         (2) EFFECTIVE                   DATE.—This                subsection shall
                                  14               take effect as if enacted on December 17, 2012.
                                  15               (f) INDEPENDENT EVALUATION.—Section 319L of
                                  16 the Public Health Service Act (42 U.S.C. 247d–7e) is
                                  17 amended by adding at the end the following:
                                  18               ‘‘(f) INDEPENDENT EVALUATION.—
                                  19                         ‘‘(1) IN        GENERAL.—Not                     later than 180 days
                                  20               after the date of enactment of this subsection, the
                                  21               Comptroller General of the United States shall con-
                                  22               duct an independent evaluation of the activities car-
                                  23               ried out to facilitate flexible manufacturing capacity
                                  24               pursuant to this section.





                                              •S 242 IS

                                                                                         94
                                    1                        ‘‘(2) REPORT.—Not later than 1 year after the
                                    2              date of enactment of this subsection, the Comp-
                                    3              troller General of the United States shall submit to
                                    4              the appropriate committees of Congress a report
                                    5              concerning the results of the evaluation conducted
                                    6              under paragraph (1). Such report shall review and
                                    7              assess—
                                    8                                 ‘‘(A) the extent to which flexible manufac-
                                    9                        turing capacity under this section is dedicated
                                  10                         to chemical, biological, radiological, and nuclear
                                  11                         threats;
                                  12                                  ‘‘(B) the activities supported by flexible
                                  13                         manufacturing initiatives; and
                                  14                                  ‘‘(C) the ability of flexible manufacturing
                                  15                         activities carried out under this section to—
                                  16                                         ‘‘(i) secure and leverage leading tech-
                                  17                                  nical expertise with respect to counter-
                                  18                                  measure advanced research, development,
                                  19                                  and manufacturing processes; and
                                  20                                         ‘‘(ii) meet the surge manufacturing
                                  21                                  capacity needs presented by novel and
                                  22                                  emerging threats, including chemical, bio-
                                  23                                  logical, radiological, and nuclear agents.’’.
                                  24               (g) DEFINITIONS.—
                                              •S 242 IS

                                                                                         95
                                    1                        (1)      QUALIFIED                COUNTERMEASURE.—Section
                                    2              319F–1(a)(2)(A) of the Public Health Service Act
                                    3              (42 U.S.C. 247d–6a(a)(2)(A)) is amended—
                                    4                                 (A) in the matter preceding clause (i), by
                                    5                        striking ‘‘to—’’ and inserting ‘‘—’’;
                                    6                                 (B) in clause (i)—
                                    7                                        (i) by striking ‘‘diagnose’’ and insert-
                                    8                                 ing ‘‘to diagnose’’; and
                                    9                                        (ii) by striking ‘‘; or’’ and inserting a
                                  10                                  semicolon;
                                  11                                  (C) in clause (ii)—
                                  12                                         (i) by striking ‘‘diagnose’’ and insert-
                                  13                                  ing ‘‘to diagnose’’; and
                                  14                                         (ii) by striking the period at the end
                                  15                                  and inserting ‘‘; or’’; and
                                  16                                  (D) by adding at the end the following:
                                  17                                         ‘‘(iii) is a product or technology in-
                                  18                                  tended to enhance the use or effect of a
                                  19                                  drug, biological product, or device de-
                                  20                                  scribed in clause (i) or (ii).’’.
                                  21                         (2) QUALIFIED                   PANDEMIC OR EPIDEMIC PROD-
                                  22               UCT.—Section               319F–3(i)(7)(A) of the Public Health
                                  23               Service Act (42 U.S.C. 247d–6d(i)(7)(A)) is amend-
                                  24               ed—





                                              •S 242 IS

                                                                                         96
                                    1                                 (A) in clause (i)(II), by striking ‘‘; or’’ and
                                    2                        inserting ‘‘;’’;
                                    3                                 (B) in clause (ii), by striking ‘‘; and’’ and
                                    4                        inserting ‘‘; or’’; and
                                    5                                 (C) by adding at the end the following:
                                    6                                        ‘‘(iii) a product or technology intended
                                    7                                 to enhance the use or effect of a drug, bio-
                                    8                                 logical product, or device described in
                                    9                                 clause (i) or (ii); and’’.
                                  10                         (3) TECHNICAL                   AMENDMENTS.—Section                   319F–
                                  11               3(i) of the Public Health Service Act (42 U.S.C.
                                  12               247d–6d(i)) is amended—
                                  13                                  (A) in paragraph (1)(C), by inserting ‘‘,
                                  14                         564A, or 564B’’ after ‘‘564’’; and
                                  15                                  (B) in paragraph (7)(B)(iii), by inserting
                                  16                         ‘‘, 564A, or 564B’’ after ‘‘564’’.
                                  17      SEC. 403. STRATEGIC NATIONAL STOCKPILE.
                                  18               Section 319F–2 of the Public Health Service Act (42
                                  19 U.S.C. 247d–6b) is amended—
                                  20                         (1) in subsection (a)—
                                  21                                  (A) in paragraph (1)—
                                  22                                         (i) by inserting ‘‘consistent with sec-
                                  23                                  tion 2811’’ before ‘‘by the Secretary to be
                                  24                                  appropriate’’; and





                                              •S 242 IS

                                                                                         97
                                    1                                        (ii) by inserting before the period at
                                    2                                 the end of the second sentence the fol-
                                    3                                 lowing: ‘‘and shall submit such review an-
                                    4                                 nually to the appropriate congressional
                                    5                                 committees of jurisdiction to the extent
                                    6                                 that disclosure of such information does
                                    7                                 not compromise national security’’; and
                                    8                                 (B) in paragraph (2)(D), by inserting be-
                                    9                        fore the semicolon at the end the following:
                                  10                         ‘‘and that the potential depletion of counter-
                                  11                         measures currently in the stockpile is identified
                                  12                         and appropriately addressed, including through
                                  13                         necessary replenishment’’; and
                                  14                         (2)        in        subsection               (f)(1),           by    striking
                                  15               ‘‘$640,000,000 for fiscal year 2002, and such sums
                                  16               as may be necessary for each of fiscal years 2003
                                  17               through 2006. Such authorization is in addition to
                                  18               amounts in the special reserve fund referred to in
                                  19               subsection (c)(10)(A).’’ and inserting ‘‘$533,800,000
                                  20               for each of fiscal years 2014 through 2018. Such
                                  21               authorization is in addition to amounts in the special
                                  22               reserve fund referred to in subsection (h).’’.
                                  23      SEC. 404. NATIONAL BIODEFENSE SCIENCE BOARD.
                                  24               Section 319M(a) of the Public Health Service Act (42




                                  25 U.S.C. 247d–f(a)) is amended—
                                              •S 242 IS

                                                                                         98
                                    1                        (1) in paragraph (2)—
                                    2                                 (A) in subparagraph (D)—
                                    3                                        (i) in clause (i), by striking ‘‘and’’ at
                                    4                                 the end;
                                    5                                        (ii) in clause (ii), by striking the pe-
                                    6                                 riod and inserting a semicolon; and
                                    7                                        (iii) by adding at the end the fol-
                                    8                                 lowing:
                                    9                                        ‘‘(iii) one such member shall be an in-
                                  10                                  dividual with pediatric subject matter ex-
                                  11                                  pertise; and
                                  12                                         ‘‘(iv) one such member shall be a
                                  13                                  State, tribal, territorial, or local public
                                  14                                  health official.’’; and
                                  15                                  (B) by adding at the end the following
                                  16                         flush sentence:
                                  17               ‘‘Nothing in this paragraph shall preclude a member
                                  18               of the Board from satisfying two or more of the re-
                                  19               quirements described in subparagraph (D).’’; and
                                  20                         (2) in paragraph (5)—
                                  21                                  (A) in subparagraph (B), by striking
                                  22                         ‘‘and’’ at the end;
                                  23                                  (B) in subparagraph (C), by striking the
                                  24                         period and inserting ‘‘; and’’; and





                                  25                                  (C) by adding at the end the following:


                                              •S 242 IS

                                                                                         99
                                    1                                 ‘‘(D) provide any recommendation, finding,
                                    2                        or report provided to the Secretary under this
                                    3                        paragraph to the appropriate committees of
                                    4                        Congress.’’.
                                              •S 242 IS                                    Æ
